[
  {
    "product_name": "Acetazolamide Extended-Release Capsules",
    "INGREDIENTS AND APPEARANCE": "ACETAZOLAMIDE EXTENDED-RELEASE\n\u00a0\t\t\n\t\t\t\t\t\n\nacetazolamide extended-release capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-243\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-243 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-243\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nACETAZOLAMIDE (UNII: O3FX965V0I)  (ACETAZOLAMIDE - UNII:O3FX965V0I) ACETAZOLAMIDE500\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ACETAZOLAMIDE (UNII: O3FX965V0I)  (ACETAZOLAMIDE - UNII:O3FX965V0I)  ACETAZOLAMIDE 500\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nACETAZOLAMIDE (UNII: O3FX965V0I)  (ACETAZOLAMIDE - UNII:O3FX965V0I)  ACETAZOLAMIDE 500\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nHYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nD&C RED NO. 28 (UNII: 767IP0Y5NH) \u00a0\n\n\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G) \u00a0\n\n\nFD&C RED NO. 40 (UNII: WZB9127XOA) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nALCOHOL (UNII: 3K9958V90M) \u00a0\n\n\nISOPROPYL ALCOHOL (UNII: ND2M416302) \u00a0\n\n\nBUTYL ALCOHOL (UNII: 8PJ61P6TS3) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 D&C RED NO. 28 (UNII: 767IP0Y5NH)  \u00a0 D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0 FD&C RED NO. 40 (UNII: WZB9127XOA)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 ALCOHOL (UNII: 3K9958V90M)  \u00a0 ISOPROPYL ALCOHOL (UNII: ND2M416302)  \u00a0 BUTYL ALCOHOL (UNII: 8PJ61P6TS3)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nHYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nD&C RED NO. 28 (UNII: 767IP0Y5NH)  \u00a0\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0\nFD&C RED NO. 40 (UNII: WZB9127XOA)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nALCOHOL (UNII: 3K9958V90M)  \u00a0\nISOPROPYL ALCOHOL (UNII: ND2M416302)  \u00a0\nBUTYL ALCOHOL (UNII: 8PJ61P6TS3)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColororange (Opaque orange) Scoreno score\n\n\nShapeCAPSULESize23mm\n\n\nFlavorImprint Code\n                           \n                           M;26\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color orange (Opaque orange)  Score no score Shape CAPSULE Size 23mm Flavor  Imprint Code \n                           \n                           M;26\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor orange (Opaque orange)  Score no score\nShape CAPSULE Size 23mm\nFlavor  Imprint Code \n                           \n                           M;26\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-243-01100  in 1 BOTTLE; Type 0: Not a Combination Product12/01/2020\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-243-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 12/01/2020 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-243-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 12/01/2020 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20740112/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207401 12/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207401 12/01/2020 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-243) , label(42571-243) , manufacture(42571-243) , pack(42571-243) \nACETAZOLAMIDE EXTENDED-RELEASE\n\u00a0\t\t\n\t\t\t\t\t\n\nacetazolamide extended-release capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-243\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-243 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-243\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nACETAZOLAMIDE (UNII: O3FX965V0I)  (ACETAZOLAMIDE - UNII:O3FX965V0I) ACETAZOLAMIDE500\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ACETAZOLAMIDE (UNII: O3FX965V0I)  (ACETAZOLAMIDE - UNII:O3FX965V0I)  ACETAZOLAMIDE 500\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nACETAZOLAMIDE (UNII: O3FX965V0I)  (ACETAZOLAMIDE - UNII:O3FX965V0I)  ACETAZOLAMIDE 500\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nHYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nD&C RED NO. 28 (UNII: 767IP0Y5NH) \u00a0\n\n\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G) \u00a0\n\n\nFD&C RED NO. 40 (UNII: WZB9127XOA) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nALCOHOL (UNII: 3K9958V90M) \u00a0\n\n\nISOPROPYL ALCOHOL (UNII: ND2M416302) \u00a0\n\n\nBUTYL ALCOHOL (UNII: 8PJ61P6TS3) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 D&C RED NO. 28 (UNII: 767IP0Y5NH)  \u00a0 D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0 FD&C RED NO. 40 (UNII: WZB9127XOA)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 ALCOHOL (UNII: 3K9958V90M)  \u00a0 ISOPROPYL ALCOHOL (UNII: ND2M416302)  \u00a0 BUTYL ALCOHOL (UNII: 8PJ61P6TS3)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nHYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nD&C RED NO. 28 (UNII: 767IP0Y5NH)  \u00a0\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0\nFD&C RED NO. 40 (UNII: WZB9127XOA)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nALCOHOL (UNII: 3K9958V90M)  \u00a0\nISOPROPYL ALCOHOL (UNII: ND2M416302)  \u00a0\nBUTYL ALCOHOL (UNII: 8PJ61P6TS3)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColororange (Opaque orange) Scoreno score\n\n\nShapeCAPSULESize23mm\n\n\nFlavorImprint Code\n                           \n                           M;26\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color orange (Opaque orange)  Score no score Shape CAPSULE Size 23mm Flavor  Imprint Code \n                           \n                           M;26\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor orange (Opaque orange)  Score no score\nShape CAPSULE Size 23mm\nFlavor  Imprint Code \n                           \n                           M;26\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-243-01100  in 1 BOTTLE; Type 0: Not a Combination Product12/01/2020\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-243-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 12/01/2020 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-243-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 12/01/2020 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20740112/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207401 12/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207401 12/01/2020 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-243) , label(42571-243) , manufacture(42571-243) , pack(42571-243) \nACETAZOLAMIDE EXTENDED-RELEASE\n\u00a0\t\t\n\t\t\t\t\t\n\nacetazolamide extended-release capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-243\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-243 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-243\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nACETAZOLAMIDE (UNII: O3FX965V0I)  (ACETAZOLAMIDE - UNII:O3FX965V0I) ACETAZOLAMIDE500\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ACETAZOLAMIDE (UNII: O3FX965V0I)  (ACETAZOLAMIDE - UNII:O3FX965V0I)  ACETAZOLAMIDE 500\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nACETAZOLAMIDE (UNII: O3FX965V0I)  (ACETAZOLAMIDE - UNII:O3FX965V0I)  ACETAZOLAMIDE 500\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nHYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nD&C RED NO. 28 (UNII: 767IP0Y5NH) \u00a0\n\n\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G) \u00a0\n\n\nFD&C RED NO. 40 (UNII: WZB9127XOA) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nALCOHOL (UNII: 3K9958V90M) \u00a0\n\n\nISOPROPYL ALCOHOL (UNII: ND2M416302) \u00a0\n\n\nBUTYL ALCOHOL (UNII: 8PJ61P6TS3) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 D&C RED NO. 28 (UNII: 767IP0Y5NH)  \u00a0 D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0 FD&C RED NO. 40 (UNII: WZB9127XOA)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 ALCOHOL (UNII: 3K9958V90M)  \u00a0 ISOPROPYL ALCOHOL (UNII: ND2M416302)  \u00a0 BUTYL ALCOHOL (UNII: 8PJ61P6TS3)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nHYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nD&C RED NO. 28 (UNII: 767IP0Y5NH)  \u00a0\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0\nFD&C RED NO. 40 (UNII: WZB9127XOA)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nALCOHOL (UNII: 3K9958V90M)  \u00a0\nISOPROPYL ALCOHOL (UNII: ND2M416302)  \u00a0\nBUTYL ALCOHOL (UNII: 8PJ61P6TS3)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColororange (Opaque orange) Scoreno score\n\n\nShapeCAPSULESize23mm\n\n\nFlavorImprint Code\n                           \n                           M;26\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color orange (Opaque orange)  Score no score Shape CAPSULE Size 23mm Flavor  Imprint Code \n                           \n                           M;26\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor orange (Opaque orange)  Score no score\nShape CAPSULE Size 23mm\nFlavor  Imprint Code \n                           \n                           M;26\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-243-01100  in 1 BOTTLE; Type 0: Not a Combination Product12/01/2020\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-243-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 12/01/2020 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-243-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 12/01/2020 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20740112/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207401 12/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207401 12/01/2020 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-243) , label(42571-243) , manufacture(42571-243) , pack(42571-243)",
    "dosage": null,
    "contraindications": null,
    "side_effects": null,
    "warnings": null
  },
  {
    "product_name": "Amlodipine Besylate and Olmesartan Medoxomil Tablets",
    "INGREDIENTS AND APPEARANCE": "AMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-235\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-235 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-235\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE5\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhiteScoreno score\n\n\nShapeROUND (biconvex) Size6mm\n\n\nFlavorImprint Code\n                           \n                           81;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white Score no score Shape ROUND (biconvex)  Size 6mm Flavor  Imprint Code \n                           \n                           81;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white Score no score\nShape ROUND (biconvex)  Size 6mm\nFlavor  Imprint Code \n                           \n                           81;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-235-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-235-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-235-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-235-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-235-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-235-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-235-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-235-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-235-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-235-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-235-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-235-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-236\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-236 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-236\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE10\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColororange (Grayish orange) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           83;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color orange (Grayish orange)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           83;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor orange (Grayish orange)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           83;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-236-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-236-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-236-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-236-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-236-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-236-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-236-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-236-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-236-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-236-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-236-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-236-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-237\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-237 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-237\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE5\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColoryellow (Cream) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           82;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color yellow (Cream)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           82;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor yellow (Cream)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           82;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-237-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-237-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-237-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-237-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-237-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-237-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-237-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-237-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-237-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-237-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-237-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-237-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-238\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-238 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-238\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE10\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorred (Brownish red) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           84;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color red (Brownish red)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           84;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor red (Brownish red)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           84;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-238-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-238-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-238-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-238-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-238-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-238-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-238-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-238-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-238-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-238-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-238-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-238-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-235, 42571-236, 42571-237, 42571-238) , label(42571-235, 42571-236, 42571-237, 42571-238) , manufacture(42571-235, 42571-236, 42571-237, 42571-238) , pack(42571-235, 42571-236, 42571-237, 42571-238) \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-235\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-235 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-235\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE5\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhiteScoreno score\n\n\nShapeROUND (biconvex) Size6mm\n\n\nFlavorImprint Code\n                           \n                           81;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white Score no score Shape ROUND (biconvex)  Size 6mm Flavor  Imprint Code \n                           \n                           81;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white Score no score\nShape ROUND (biconvex)  Size 6mm\nFlavor  Imprint Code \n                           \n                           81;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-235-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-235-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-235-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-235-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-235-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-235-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-235-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-235-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-235-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-235-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-235-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-235-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-236\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-236 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-236\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE10\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColororange (Grayish orange) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           83;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color orange (Grayish orange)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           83;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor orange (Grayish orange)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           83;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-236-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-236-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-236-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-236-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-236-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-236-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-236-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-236-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-236-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-236-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-236-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-236-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-237\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-237 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-237\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE5\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColoryellow (Cream) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           82;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color yellow (Cream)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           82;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor yellow (Cream)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           82;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-237-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-237-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-237-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-237-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-237-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-237-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-237-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-237-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-237-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-237-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-237-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-237-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-238\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-238 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-238\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE10\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorred (Brownish red) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           84;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color red (Brownish red)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           84;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor red (Brownish red)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           84;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-238-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-238-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-238-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-238-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-238-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-238-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-238-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-238-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-238-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-238-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-238-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-238-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-235, 42571-236, 42571-237, 42571-238) , label(42571-235, 42571-236, 42571-237, 42571-238) , manufacture(42571-235, 42571-236, 42571-237, 42571-238) , pack(42571-235, 42571-236, 42571-237, 42571-238) \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-235\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-235 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-235\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE5\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhiteScoreno score\n\n\nShapeROUND (biconvex) Size6mm\n\n\nFlavorImprint Code\n                           \n                           81;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white Score no score Shape ROUND (biconvex)  Size 6mm Flavor  Imprint Code \n                           \n                           81;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white Score no score\nShape ROUND (biconvex)  Size 6mm\nFlavor  Imprint Code \n                           \n                           81;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-235-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-235-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-235-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-235-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-235-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-235-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-235-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-235-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-235-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-235-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-235-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-235-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-236\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-236 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-236\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE10\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColororange (Grayish orange) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           83;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color orange (Grayish orange)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           83;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor orange (Grayish orange)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           83;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-236-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-236-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-236-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-236-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-236-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-236-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-236-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-236-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-236-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-236-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-236-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-236-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-237\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-237 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-237\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE5\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColoryellow (Cream) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           82;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color yellow (Cream)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           82;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor yellow (Cream)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           82;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-237-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-237-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-237-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-237-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-237-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-237-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-237-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-237-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-237-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-237-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-237-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-237-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-238\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-238 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-238\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE10\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorred (Brownish red) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           84;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color red (Brownish red)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           84;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor red (Brownish red)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           84;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-238-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-238-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-238-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-238-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-238-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-238-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-238-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-238-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-238-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-238-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-238-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-238-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-235, 42571-236, 42571-237, 42571-238) , label(42571-235, 42571-236, 42571-237, 42571-238) , manufacture(42571-235, 42571-236, 42571-237, 42571-238) , pack(42571-235, 42571-236, 42571-237, 42571-238) \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-235\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-235 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-235\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE5\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhiteScoreno score\n\n\nShapeROUND (biconvex) Size6mm\n\n\nFlavorImprint Code\n                           \n                           81;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white Score no score Shape ROUND (biconvex)  Size 6mm Flavor  Imprint Code \n                           \n                           81;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white Score no score\nShape ROUND (biconvex)  Size 6mm\nFlavor  Imprint Code \n                           \n                           81;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-235-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-235-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-235-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-235-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-235-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-235-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-235-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-235-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-235-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-235-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-235-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-235-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-236\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-236 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-236\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE10\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColororange (Grayish orange) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           83;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color orange (Grayish orange)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           83;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor orange (Grayish orange)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           83;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-236-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-236-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-236-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-236-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-236-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-236-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-236-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-236-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-236-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-236-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-236-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-236-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-237\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-237 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-237\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE5\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColoryellow (Cream) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           82;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color yellow (Cream)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           82;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor yellow (Cream)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           82;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-237-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-237-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-237-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-237-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-237-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-237-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-237-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-237-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-237-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-237-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-237-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-237-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-238\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-238 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-238\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE10\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorred (Brownish red) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           84;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color red (Brownish red)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           84;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor red (Brownish red)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           84;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-238-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-238-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-238-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-238-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-238-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-238-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-238-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-238-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-238-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-238-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-238-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-238-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-235, 42571-236, 42571-237, 42571-238) , label(42571-235, 42571-236, 42571-237, 42571-238) , manufacture(42571-235, 42571-236, 42571-237, 42571-238) , pack(42571-235, 42571-236, 42571-237, 42571-238) \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-235\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-235 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-235\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE5\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhiteScoreno score\n\n\nShapeROUND (biconvex) Size6mm\n\n\nFlavorImprint Code\n                           \n                           81;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white Score no score Shape ROUND (biconvex)  Size 6mm Flavor  Imprint Code \n                           \n                           81;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white Score no score\nShape ROUND (biconvex)  Size 6mm\nFlavor  Imprint Code \n                           \n                           81;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-235-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-235-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-235-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-235-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-235-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-235-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-235-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-235-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-235-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-235-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-235-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-235-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-236\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-236 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-236\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE10\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColororange (Grayish orange) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           83;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color orange (Grayish orange)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           83;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor orange (Grayish orange)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           83;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-236-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-236-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-236-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-236-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-236-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-236-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-236-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-236-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-236-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-236-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-236-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-236-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-237\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-237 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-237\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE5\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColoryellow (Cream) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           82;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color yellow (Cream)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           82;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor yellow (Cream)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           82;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-237-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-237-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-237-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-237-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-237-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-237-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-237-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-237-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-237-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-237-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-237-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-237-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-238\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-238 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-238\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE10\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorred (Brownish red) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           84;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color red (Brownish red)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           84;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor red (Brownish red)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           84;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-238-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-238-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-238-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-238-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-238-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-238-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-238-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-238-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-238-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-238-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-238-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-238-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-235, 42571-236, 42571-237, 42571-238) , label(42571-235, 42571-236, 42571-237, 42571-238) , manufacture(42571-235, 42571-236, 42571-237, 42571-238) , pack(42571-235, 42571-236, 42571-237, 42571-238) \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-235\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-235 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-235\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE5\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhiteScoreno score\n\n\nShapeROUND (biconvex) Size6mm\n\n\nFlavorImprint Code\n                           \n                           81;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white Score no score Shape ROUND (biconvex)  Size 6mm Flavor  Imprint Code \n                           \n                           81;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white Score no score\nShape ROUND (biconvex)  Size 6mm\nFlavor  Imprint Code \n                           \n                           81;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-235-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-235-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-235-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-235-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-235-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-235-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-235-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-235-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-235-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-235-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-235-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-235-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-236\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-236 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-236\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE10\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColororange (Grayish orange) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           83;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color orange (Grayish orange)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           83;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor orange (Grayish orange)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           83;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-236-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-236-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-236-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-236-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-236-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-236-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-236-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-236-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-236-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-236-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-236-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-236-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-237\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-237 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-237\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE5\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 5\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColoryellow (Cream) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           82;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color yellow (Cream)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           82;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor yellow (Cream)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           82;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-237-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-237-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-237-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-237-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-237-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-237-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-237-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-237-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-237-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-237-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-237-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-237-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nAMLODIPINE AND OLMESARTAN MEDOXOMIL\u00a0\t\t\n\t\t\t\t\t\n\namlodipine and olmesartan medoxomil tablet\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-238\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-238 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-238\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288) AMLODIPINE10\u00a0mg\n\n\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10) OLMESARTAN MEDOXOMIL40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg OLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMLODIPINE BESYLATE (UNII: 864V2Q084H)  (AMLODIPINE - UNII:1J444QC288)  AMLODIPINE 10\u00a0mg\nOLMESARTAN MEDOXOMIL (UNII: 6M97XTV3HD)  (OLMESARTAN - UNII:8W1IQP3U10)  OLMESARTAN MEDOXOMIL 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorred (Brownish red) Scoreno score\n\n\nShapeROUND (biconvex) Size8mm\n\n\nFlavorImprint Code\n                           \n                           84;I\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color red (Brownish red)  Score no score Shape ROUND (biconvex)  Size 8mm Flavor  Imprint Code \n                           \n                           84;I\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor red (Brownish red)  Score no score\nShape ROUND (biconvex)  Size 8mm\nFlavor  Imprint Code \n                           \n                           84;I\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-238-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n2NDC:42571-238-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n3NDC:42571-238-05500  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n4NDC:42571-238-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-238-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  2 NDC:42571-238-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  3 NDC:42571-238-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018  4 NDC:42571-238-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-238-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n2 NDC:42571-238-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n3 NDC:42571-238-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n4 NDC:42571-238-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20743501/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207435 01/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207435 01/01/2018 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-235, 42571-236, 42571-237, 42571-238) , label(42571-235, 42571-236, 42571-237, 42571-238) , manufacture(42571-235, 42571-236, 42571-237, 42571-238) , pack(42571-235, 42571-236, 42571-237, 42571-238)",
    "dosage": null,
    "contraindications": null,
    "side_effects": null,
    "warnings": null
  },
  {
    "product_name": "Amoxicillin and Clavulanate Potassium for Oral Suspension, USP",
    "INGREDIENTS AND APPEARANCE": "AMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium powder, for suspension\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-163\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-163 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-163\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS200\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID28.5\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 200\u00a0mg \u00a0in\u00a05\u00a0mL CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 28.5\u00a0mg \u00a0in\u00a05\u00a0mL\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 200\u00a0mg \u00a0in\u00a05\u00a0mL\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 28.5\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nASPARTAME (UNII: Z0H242BBR1) \u00a0\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nCARAMEL (UNII: T9D99G2B1R) \u00a0\n\n\nORANGE (UNII: 5EVU04N5QU) \u00a0\n\n\nRASPBERRY (UNII: 4N14V5R27W) \u00a0\n\n\nSUCCINIC ACID (UNII: AB6MNQ6J6L) \u00a0\n\n\nXANTHAN GUM (UNII: TTV12P4NEE) \u00a0\n\n\nMALTODEXTRIN (UNII: 7CVR7L4A2D) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nACETIC ACID (UNII: Q40Q9N063P) \u00a0\n\n\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength ASPARTAME (UNII: Z0H242BBR1)  \u00a0 SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 CARAMEL (UNII: T9D99G2B1R)  \u00a0 ORANGE (UNII: 5EVU04N5QU)  \u00a0 RASPBERRY (UNII: 4N14V5R27W)  \u00a0 SUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0 XANTHAN GUM (UNII: TTV12P4NEE)  \u00a0 MALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 ACETIC ACID (UNII: Q40Q9N063P)  \u00a0 TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nASPARTAME (UNII: Z0H242BBR1)  \u00a0\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nCARAMEL (UNII: T9D99G2B1R)  \u00a0\nORANGE (UNII: 5EVU04N5QU)  \u00a0\nRASPBERRY (UNII: 4N14V5R27W)  \u00a0\nSUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0\nXANTHAN GUM (UNII: TTV12P4NEE)  \u00a0\nMALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nACETIC ACID (UNII: Q40Q9N063P)  \u00a0\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Score\u00a0\u00a0\u00a0\u00a0\n\n\nShapeSize\n\n\nFlavorCARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRYImprint Code\n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0 Shape  Size  Flavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code  Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0\nShape  Size \nFlavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-163-47100 mL in 1 BOTTLE; Type 0: Not a Combination Product07/01/2021\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-163-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-163-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20518707/01/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205187 07/01/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205187 07/01/2021 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium powder, for suspension\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-164\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-164 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-164\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS400\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID57\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 400\u00a0mg \u00a0in\u00a05\u00a0mL CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 57\u00a0mg \u00a0in\u00a05\u00a0mL\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 400\u00a0mg \u00a0in\u00a05\u00a0mL\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 57\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nASPARTAME (UNII: Z0H242BBR1) \u00a0\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nCARAMEL (UNII: T9D99G2B1R) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nORANGE (UNII: 5EVU04N5QU) \u00a0\n\n\nRASPBERRY (UNII: 4N14V5R27W) \u00a0\n\n\nSUCCINIC ACID (UNII: AB6MNQ6J6L) \u00a0\n\n\nXANTHAN GUM (UNII: TTV12P4NEE) \u00a0\n\n\nMALTODEXTRIN (UNII: 7CVR7L4A2D) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nACETIC ACID (UNII: Q40Q9N063P) \u00a0\n\n\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength ASPARTAME (UNII: Z0H242BBR1)  \u00a0 SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 CARAMEL (UNII: T9D99G2B1R)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 ORANGE (UNII: 5EVU04N5QU)  \u00a0 RASPBERRY (UNII: 4N14V5R27W)  \u00a0 SUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0 XANTHAN GUM (UNII: TTV12P4NEE)  \u00a0 MALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 ACETIC ACID (UNII: Q40Q9N063P)  \u00a0 TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nASPARTAME (UNII: Z0H242BBR1)  \u00a0\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nCARAMEL (UNII: T9D99G2B1R)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nORANGE (UNII: 5EVU04N5QU)  \u00a0\nRASPBERRY (UNII: 4N14V5R27W)  \u00a0\nSUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0\nXANTHAN GUM (UNII: TTV12P4NEE)  \u00a0\nMALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nACETIC ACID (UNII: Q40Q9N063P)  \u00a0\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Score\u00a0\u00a0\u00a0\u00a0\n\n\nShapeSize\n\n\nFlavorCARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRYImprint Code\n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0 Shape  Size  Flavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code  Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0\nShape  Size \nFlavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-164-47100 mL in 1 BOTTLE; Type 0: Not a Combination Product07/01/2021\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-164-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-164-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20518707/01/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205187 07/01/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205187 07/01/2021 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  867064609 analysis(42571-163, 42571-164) , label(42571-163, 42571-164) , manufacture(42571-163, 42571-164) , pack(42571-163, 42571-164) \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium powder, for suspension\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-163\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-163 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-163\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS200\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID28.5\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 200\u00a0mg \u00a0in\u00a05\u00a0mL CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 28.5\u00a0mg \u00a0in\u00a05\u00a0mL\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 200\u00a0mg \u00a0in\u00a05\u00a0mL\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 28.5\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nASPARTAME (UNII: Z0H242BBR1) \u00a0\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nCARAMEL (UNII: T9D99G2B1R) \u00a0\n\n\nORANGE (UNII: 5EVU04N5QU) \u00a0\n\n\nRASPBERRY (UNII: 4N14V5R27W) \u00a0\n\n\nSUCCINIC ACID (UNII: AB6MNQ6J6L) \u00a0\n\n\nXANTHAN GUM (UNII: TTV12P4NEE) \u00a0\n\n\nMALTODEXTRIN (UNII: 7CVR7L4A2D) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nACETIC ACID (UNII: Q40Q9N063P) \u00a0\n\n\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength ASPARTAME (UNII: Z0H242BBR1)  \u00a0 SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 CARAMEL (UNII: T9D99G2B1R)  \u00a0 ORANGE (UNII: 5EVU04N5QU)  \u00a0 RASPBERRY (UNII: 4N14V5R27W)  \u00a0 SUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0 XANTHAN GUM (UNII: TTV12P4NEE)  \u00a0 MALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 ACETIC ACID (UNII: Q40Q9N063P)  \u00a0 TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nASPARTAME (UNII: Z0H242BBR1)  \u00a0\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nCARAMEL (UNII: T9D99G2B1R)  \u00a0\nORANGE (UNII: 5EVU04N5QU)  \u00a0\nRASPBERRY (UNII: 4N14V5R27W)  \u00a0\nSUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0\nXANTHAN GUM (UNII: TTV12P4NEE)  \u00a0\nMALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nACETIC ACID (UNII: Q40Q9N063P)  \u00a0\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Score\u00a0\u00a0\u00a0\u00a0\n\n\nShapeSize\n\n\nFlavorCARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRYImprint Code\n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0 Shape  Size  Flavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code  Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0\nShape  Size \nFlavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-163-47100 mL in 1 BOTTLE; Type 0: Not a Combination Product07/01/2021\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-163-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-163-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20518707/01/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205187 07/01/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205187 07/01/2021 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium powder, for suspension\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-164\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-164 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-164\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS400\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID57\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 400\u00a0mg \u00a0in\u00a05\u00a0mL CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 57\u00a0mg \u00a0in\u00a05\u00a0mL\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 400\u00a0mg \u00a0in\u00a05\u00a0mL\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 57\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nASPARTAME (UNII: Z0H242BBR1) \u00a0\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nCARAMEL (UNII: T9D99G2B1R) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nORANGE (UNII: 5EVU04N5QU) \u00a0\n\n\nRASPBERRY (UNII: 4N14V5R27W) \u00a0\n\n\nSUCCINIC ACID (UNII: AB6MNQ6J6L) \u00a0\n\n\nXANTHAN GUM (UNII: TTV12P4NEE) \u00a0\n\n\nMALTODEXTRIN (UNII: 7CVR7L4A2D) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nACETIC ACID (UNII: Q40Q9N063P) \u00a0\n\n\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength ASPARTAME (UNII: Z0H242BBR1)  \u00a0 SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 CARAMEL (UNII: T9D99G2B1R)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 ORANGE (UNII: 5EVU04N5QU)  \u00a0 RASPBERRY (UNII: 4N14V5R27W)  \u00a0 SUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0 XANTHAN GUM (UNII: TTV12P4NEE)  \u00a0 MALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 ACETIC ACID (UNII: Q40Q9N063P)  \u00a0 TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nASPARTAME (UNII: Z0H242BBR1)  \u00a0\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nCARAMEL (UNII: T9D99G2B1R)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nORANGE (UNII: 5EVU04N5QU)  \u00a0\nRASPBERRY (UNII: 4N14V5R27W)  \u00a0\nSUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0\nXANTHAN GUM (UNII: TTV12P4NEE)  \u00a0\nMALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nACETIC ACID (UNII: Q40Q9N063P)  \u00a0\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Score\u00a0\u00a0\u00a0\u00a0\n\n\nShapeSize\n\n\nFlavorCARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRYImprint Code\n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0 Shape  Size  Flavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code  Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0\nShape  Size \nFlavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-164-47100 mL in 1 BOTTLE; Type 0: Not a Combination Product07/01/2021\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-164-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-164-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20518707/01/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205187 07/01/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205187 07/01/2021 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  867064609 analysis(42571-163, 42571-164) , label(42571-163, 42571-164) , manufacture(42571-163, 42571-164) , pack(42571-163, 42571-164) \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium powder, for suspension\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-163\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-163 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-163\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS200\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID28.5\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 200\u00a0mg \u00a0in\u00a05\u00a0mL CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 28.5\u00a0mg \u00a0in\u00a05\u00a0mL\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 200\u00a0mg \u00a0in\u00a05\u00a0mL\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 28.5\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nASPARTAME (UNII: Z0H242BBR1) \u00a0\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nCARAMEL (UNII: T9D99G2B1R) \u00a0\n\n\nORANGE (UNII: 5EVU04N5QU) \u00a0\n\n\nRASPBERRY (UNII: 4N14V5R27W) \u00a0\n\n\nSUCCINIC ACID (UNII: AB6MNQ6J6L) \u00a0\n\n\nXANTHAN GUM (UNII: TTV12P4NEE) \u00a0\n\n\nMALTODEXTRIN (UNII: 7CVR7L4A2D) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nACETIC ACID (UNII: Q40Q9N063P) \u00a0\n\n\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength ASPARTAME (UNII: Z0H242BBR1)  \u00a0 SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 CARAMEL (UNII: T9D99G2B1R)  \u00a0 ORANGE (UNII: 5EVU04N5QU)  \u00a0 RASPBERRY (UNII: 4N14V5R27W)  \u00a0 SUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0 XANTHAN GUM (UNII: TTV12P4NEE)  \u00a0 MALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 ACETIC ACID (UNII: Q40Q9N063P)  \u00a0 TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nASPARTAME (UNII: Z0H242BBR1)  \u00a0\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nCARAMEL (UNII: T9D99G2B1R)  \u00a0\nORANGE (UNII: 5EVU04N5QU)  \u00a0\nRASPBERRY (UNII: 4N14V5R27W)  \u00a0\nSUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0\nXANTHAN GUM (UNII: TTV12P4NEE)  \u00a0\nMALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nACETIC ACID (UNII: Q40Q9N063P)  \u00a0\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Score\u00a0\u00a0\u00a0\u00a0\n\n\nShapeSize\n\n\nFlavorCARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRYImprint Code\n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0 Shape  Size  Flavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code  Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0\nShape  Size \nFlavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-163-47100 mL in 1 BOTTLE; Type 0: Not a Combination Product07/01/2021\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-163-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-163-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20518707/01/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205187 07/01/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205187 07/01/2021 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium powder, for suspension\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-164\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-164 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-164\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS400\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID57\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 400\u00a0mg \u00a0in\u00a05\u00a0mL CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 57\u00a0mg \u00a0in\u00a05\u00a0mL\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 400\u00a0mg \u00a0in\u00a05\u00a0mL\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 57\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nASPARTAME (UNII: Z0H242BBR1) \u00a0\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nCARAMEL (UNII: T9D99G2B1R) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nORANGE (UNII: 5EVU04N5QU) \u00a0\n\n\nRASPBERRY (UNII: 4N14V5R27W) \u00a0\n\n\nSUCCINIC ACID (UNII: AB6MNQ6J6L) \u00a0\n\n\nXANTHAN GUM (UNII: TTV12P4NEE) \u00a0\n\n\nMALTODEXTRIN (UNII: 7CVR7L4A2D) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nACETIC ACID (UNII: Q40Q9N063P) \u00a0\n\n\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength ASPARTAME (UNII: Z0H242BBR1)  \u00a0 SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 CARAMEL (UNII: T9D99G2B1R)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 ORANGE (UNII: 5EVU04N5QU)  \u00a0 RASPBERRY (UNII: 4N14V5R27W)  \u00a0 SUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0 XANTHAN GUM (UNII: TTV12P4NEE)  \u00a0 MALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 ACETIC ACID (UNII: Q40Q9N063P)  \u00a0 TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nASPARTAME (UNII: Z0H242BBR1)  \u00a0\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nCARAMEL (UNII: T9D99G2B1R)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nORANGE (UNII: 5EVU04N5QU)  \u00a0\nRASPBERRY (UNII: 4N14V5R27W)  \u00a0\nSUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0\nXANTHAN GUM (UNII: TTV12P4NEE)  \u00a0\nMALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nACETIC ACID (UNII: Q40Q9N063P)  \u00a0\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Score\u00a0\u00a0\u00a0\u00a0\n\n\nShapeSize\n\n\nFlavorCARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRYImprint Code\n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0 Shape  Size  Flavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code  Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0\nShape  Size \nFlavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-164-47100 mL in 1 BOTTLE; Type 0: Not a Combination Product07/01/2021\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-164-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-164-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20518707/01/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205187 07/01/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205187 07/01/2021 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  867064609 analysis(42571-163, 42571-164) , label(42571-163, 42571-164) , manufacture(42571-163, 42571-164) , pack(42571-163, 42571-164) \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium powder, for suspension\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-163\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-163 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-163\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS200\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID28.5\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 200\u00a0mg \u00a0in\u00a05\u00a0mL CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 28.5\u00a0mg \u00a0in\u00a05\u00a0mL\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 200\u00a0mg \u00a0in\u00a05\u00a0mL\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 28.5\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nASPARTAME (UNII: Z0H242BBR1) \u00a0\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nCARAMEL (UNII: T9D99G2B1R) \u00a0\n\n\nORANGE (UNII: 5EVU04N5QU) \u00a0\n\n\nRASPBERRY (UNII: 4N14V5R27W) \u00a0\n\n\nSUCCINIC ACID (UNII: AB6MNQ6J6L) \u00a0\n\n\nXANTHAN GUM (UNII: TTV12P4NEE) \u00a0\n\n\nMALTODEXTRIN (UNII: 7CVR7L4A2D) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nACETIC ACID (UNII: Q40Q9N063P) \u00a0\n\n\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength ASPARTAME (UNII: Z0H242BBR1)  \u00a0 SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 CARAMEL (UNII: T9D99G2B1R)  \u00a0 ORANGE (UNII: 5EVU04N5QU)  \u00a0 RASPBERRY (UNII: 4N14V5R27W)  \u00a0 SUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0 XANTHAN GUM (UNII: TTV12P4NEE)  \u00a0 MALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 ACETIC ACID (UNII: Q40Q9N063P)  \u00a0 TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nASPARTAME (UNII: Z0H242BBR1)  \u00a0\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nCARAMEL (UNII: T9D99G2B1R)  \u00a0\nORANGE (UNII: 5EVU04N5QU)  \u00a0\nRASPBERRY (UNII: 4N14V5R27W)  \u00a0\nSUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0\nXANTHAN GUM (UNII: TTV12P4NEE)  \u00a0\nMALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nACETIC ACID (UNII: Q40Q9N063P)  \u00a0\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Score\u00a0\u00a0\u00a0\u00a0\n\n\nShapeSize\n\n\nFlavorCARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRYImprint Code\n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0 Shape  Size  Flavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code  Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0\nShape  Size \nFlavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-163-47100 mL in 1 BOTTLE; Type 0: Not a Combination Product07/01/2021\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-163-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-163-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20518707/01/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205187 07/01/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205187 07/01/2021 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium powder, for suspension\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-164\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-164 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-164\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS400\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID57\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 400\u00a0mg \u00a0in\u00a05\u00a0mL CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 57\u00a0mg \u00a0in\u00a05\u00a0mL\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 400\u00a0mg \u00a0in\u00a05\u00a0mL\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 57\u00a0mg \u00a0in\u00a05\u00a0mL\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nASPARTAME (UNII: Z0H242BBR1) \u00a0\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nCARAMEL (UNII: T9D99G2B1R) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nORANGE (UNII: 5EVU04N5QU) \u00a0\n\n\nRASPBERRY (UNII: 4N14V5R27W) \u00a0\n\n\nSUCCINIC ACID (UNII: AB6MNQ6J6L) \u00a0\n\n\nXANTHAN GUM (UNII: TTV12P4NEE) \u00a0\n\n\nMALTODEXTRIN (UNII: 7CVR7L4A2D) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nACETIC ACID (UNII: Q40Q9N063P) \u00a0\n\n\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength ASPARTAME (UNII: Z0H242BBR1)  \u00a0 SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 CARAMEL (UNII: T9D99G2B1R)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 ORANGE (UNII: 5EVU04N5QU)  \u00a0 RASPBERRY (UNII: 4N14V5R27W)  \u00a0 SUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0 XANTHAN GUM (UNII: TTV12P4NEE)  \u00a0 MALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 ACETIC ACID (UNII: Q40Q9N063P)  \u00a0 TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nASPARTAME (UNII: Z0H242BBR1)  \u00a0\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nCARAMEL (UNII: T9D99G2B1R)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nORANGE (UNII: 5EVU04N5QU)  \u00a0\nRASPBERRY (UNII: 4N14V5R27W)  \u00a0\nSUCCINIC ACID (UNII: AB6MNQ6J6L)  \u00a0\nXANTHAN GUM (UNII: TTV12P4NEE)  \u00a0\nMALTODEXTRIN (UNII: 7CVR7L4A2D)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nACETIC ACID (UNII: Q40Q9N063P)  \u00a0\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Score\u00a0\u00a0\u00a0\u00a0\n\n\nShapeSize\n\n\nFlavorCARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRYImprint Code\n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0 Shape  Size  Flavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code  Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score \u00a0\u00a0\u00a0\u00a0\nShape  Size \nFlavor CARAMEL (golden caramel) ,\u00a0ORANGE,\u00a0RASPBERRY Imprint Code \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-164-47100 mL in 1 BOTTLE; Type 0: Not a Combination Product07/01/2021\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-164-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-164-47 100 mL in 1 BOTTLE; Type 0: Not a Combination Product 07/01/2021 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20518707/01/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205187 07/01/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205187 07/01/2021 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  867064609 analysis(42571-163, 42571-164) , label(42571-163, 42571-164) , manufacture(42571-163, 42571-164) , pack(42571-163, 42571-164)",
    "dosage": null,
    "contraindications": null,
    "side_effects": null,
    "warnings": null
  },
  {
    "product_name": "Amoxicillin and Clavulanate Potassium Tablets, USP",
    "INGREDIENTS AND APPEARANCE": "AMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-160\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-160 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-160\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS250\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeCAPSULE (biconvex) Size17mm\n\n\nFlavorImprint Code\n                           \n                           I05\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape CAPSULE (biconvex)  Size 17mm Flavor  Imprint Code \n                           \n                           I05\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape CAPSULE (biconvex)  Size 17mm\nFlavor  Imprint Code \n                           \n                           I05\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-160-3030  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-160-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-160-1110  in 1 CARTON03/01/2017\n\n\n3NDC:42571-160-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-160-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-160-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-160-11 10  in 1 CARTON 03/01/2017  3 NDC:42571-160-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-160-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-160-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-160-11 10  in 1 CARTON 03/01/2017 \n3 NDC:42571-160-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20570703/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205707 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205707 03/01/2017 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-161\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-161 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-161\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS500\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeCAPSULE (biconvex) Size19mm\n\n\nFlavorImprint Code\n                           \n                           I06\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape CAPSULE (biconvex)  Size 19mm Flavor  Imprint Code \n                           \n                           I06\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape CAPSULE (biconvex)  Size 19mm\nFlavor  Imprint Code \n                           \n                           I06\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-161-4220  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-161-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-161-1110  in 1 CARTON03/01/2017\n\n\n3NDC:42571-161-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-161-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-161-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-161-11 10  in 1 CARTON 03/01/2017  3 NDC:42571-161-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-161-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-161-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-161-11 10  in 1 CARTON 03/01/2017 \n3 NDC:42571-161-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20570703/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205707 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205707 03/01/2017 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-162\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-162 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-162\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS875\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 875\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 875\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Score2 pieces\n\n\nShapeCAPSULE (biconvex) Size22mm\n\n\nFlavorImprint Code\n                           \n                           I07\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score 2 pieces Shape CAPSULE (biconvex)  Size 22mm Flavor  Imprint Code \n                           \n                           I07\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score 2 pieces\nShape CAPSULE (biconvex)  Size 22mm\nFlavor  Imprint Code \n                           \n                           I07\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-162-4220  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-162-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-162-444  in 1 CARTON03/01/2017\n\n\n3NDC:42571-162-434  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-162-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-162-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-162-44 4  in 1 CARTON 03/01/2017  3 NDC:42571-162-43 4  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-162-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-162-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-162-44 4  in 1 CARTON 03/01/2017 \n3 NDC:42571-162-43 4  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20475503/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204755 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204755 03/01/2017 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  867064609 analysis(42571-160, 42571-161, 42571-162) , label(42571-160, 42571-161, 42571-162) , manufacture(42571-160, 42571-161, 42571-162) , pack(42571-160, 42571-161, 42571-162) \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-160\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-160 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-160\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS250\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeCAPSULE (biconvex) Size17mm\n\n\nFlavorImprint Code\n                           \n                           I05\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape CAPSULE (biconvex)  Size 17mm Flavor  Imprint Code \n                           \n                           I05\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape CAPSULE (biconvex)  Size 17mm\nFlavor  Imprint Code \n                           \n                           I05\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-160-3030  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-160-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-160-1110  in 1 CARTON03/01/2017\n\n\n3NDC:42571-160-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-160-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-160-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-160-11 10  in 1 CARTON 03/01/2017  3 NDC:42571-160-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-160-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-160-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-160-11 10  in 1 CARTON 03/01/2017 \n3 NDC:42571-160-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20570703/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205707 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205707 03/01/2017 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-161\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-161 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-161\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS500\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeCAPSULE (biconvex) Size19mm\n\n\nFlavorImprint Code\n                           \n                           I06\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape CAPSULE (biconvex)  Size 19mm Flavor  Imprint Code \n                           \n                           I06\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape CAPSULE (biconvex)  Size 19mm\nFlavor  Imprint Code \n                           \n                           I06\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-161-4220  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-161-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-161-1110  in 1 CARTON03/01/2017\n\n\n3NDC:42571-161-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-161-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-161-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-161-11 10  in 1 CARTON 03/01/2017  3 NDC:42571-161-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-161-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-161-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-161-11 10  in 1 CARTON 03/01/2017 \n3 NDC:42571-161-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20570703/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205707 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205707 03/01/2017 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-162\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-162 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-162\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS875\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 875\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 875\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Score2 pieces\n\n\nShapeCAPSULE (biconvex) Size22mm\n\n\nFlavorImprint Code\n                           \n                           I07\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score 2 pieces Shape CAPSULE (biconvex)  Size 22mm Flavor  Imprint Code \n                           \n                           I07\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score 2 pieces\nShape CAPSULE (biconvex)  Size 22mm\nFlavor  Imprint Code \n                           \n                           I07\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-162-4220  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-162-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-162-444  in 1 CARTON03/01/2017\n\n\n3NDC:42571-162-434  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-162-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-162-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-162-44 4  in 1 CARTON 03/01/2017  3 NDC:42571-162-43 4  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-162-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-162-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-162-44 4  in 1 CARTON 03/01/2017 \n3 NDC:42571-162-43 4  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20475503/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204755 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204755 03/01/2017 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  867064609 analysis(42571-160, 42571-161, 42571-162) , label(42571-160, 42571-161, 42571-162) , manufacture(42571-160, 42571-161, 42571-162) , pack(42571-160, 42571-161, 42571-162) \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-160\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-160 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-160\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS250\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeCAPSULE (biconvex) Size17mm\n\n\nFlavorImprint Code\n                           \n                           I05\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape CAPSULE (biconvex)  Size 17mm Flavor  Imprint Code \n                           \n                           I05\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape CAPSULE (biconvex)  Size 17mm\nFlavor  Imprint Code \n                           \n                           I05\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-160-3030  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-160-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-160-1110  in 1 CARTON03/01/2017\n\n\n3NDC:42571-160-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-160-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-160-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-160-11 10  in 1 CARTON 03/01/2017  3 NDC:42571-160-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-160-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-160-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-160-11 10  in 1 CARTON 03/01/2017 \n3 NDC:42571-160-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20570703/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205707 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205707 03/01/2017 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-161\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-161 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-161\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS500\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeCAPSULE (biconvex) Size19mm\n\n\nFlavorImprint Code\n                           \n                           I06\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape CAPSULE (biconvex)  Size 19mm Flavor  Imprint Code \n                           \n                           I06\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape CAPSULE (biconvex)  Size 19mm\nFlavor  Imprint Code \n                           \n                           I06\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-161-4220  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-161-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-161-1110  in 1 CARTON03/01/2017\n\n\n3NDC:42571-161-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-161-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-161-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-161-11 10  in 1 CARTON 03/01/2017  3 NDC:42571-161-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-161-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-161-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-161-11 10  in 1 CARTON 03/01/2017 \n3 NDC:42571-161-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20570703/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205707 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205707 03/01/2017 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-162\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-162 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-162\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS875\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 875\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 875\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Score2 pieces\n\n\nShapeCAPSULE (biconvex) Size22mm\n\n\nFlavorImprint Code\n                           \n                           I07\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score 2 pieces Shape CAPSULE (biconvex)  Size 22mm Flavor  Imprint Code \n                           \n                           I07\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score 2 pieces\nShape CAPSULE (biconvex)  Size 22mm\nFlavor  Imprint Code \n                           \n                           I07\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-162-4220  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-162-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-162-444  in 1 CARTON03/01/2017\n\n\n3NDC:42571-162-434  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-162-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-162-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-162-44 4  in 1 CARTON 03/01/2017  3 NDC:42571-162-43 4  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-162-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-162-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-162-44 4  in 1 CARTON 03/01/2017 \n3 NDC:42571-162-43 4  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20475503/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204755 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204755 03/01/2017 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  867064609 analysis(42571-160, 42571-161, 42571-162) , label(42571-160, 42571-161, 42571-162) , manufacture(42571-160, 42571-161, 42571-162) , pack(42571-160, 42571-161, 42571-162) \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-160\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-160 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-160\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS250\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeCAPSULE (biconvex) Size17mm\n\n\nFlavorImprint Code\n                           \n                           I05\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape CAPSULE (biconvex)  Size 17mm Flavor  Imprint Code \n                           \n                           I05\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape CAPSULE (biconvex)  Size 17mm\nFlavor  Imprint Code \n                           \n                           I05\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-160-3030  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-160-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-160-1110  in 1 CARTON03/01/2017\n\n\n3NDC:42571-160-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-160-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-160-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-160-11 10  in 1 CARTON 03/01/2017  3 NDC:42571-160-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-160-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-160-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-160-11 10  in 1 CARTON 03/01/2017 \n3 NDC:42571-160-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20570703/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205707 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205707 03/01/2017 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-161\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-161 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-161\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS500\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeCAPSULE (biconvex) Size19mm\n\n\nFlavorImprint Code\n                           \n                           I06\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape CAPSULE (biconvex)  Size 19mm Flavor  Imprint Code \n                           \n                           I06\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape CAPSULE (biconvex)  Size 19mm\nFlavor  Imprint Code \n                           \n                           I06\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-161-4220  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-161-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-161-1110  in 1 CARTON03/01/2017\n\n\n3NDC:42571-161-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-161-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-161-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-161-11 10  in 1 CARTON 03/01/2017  3 NDC:42571-161-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-161-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-161-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-161-11 10  in 1 CARTON 03/01/2017 \n3 NDC:42571-161-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20570703/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205707 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205707 03/01/2017 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-162\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-162 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-162\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS875\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 875\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 875\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Score2 pieces\n\n\nShapeCAPSULE (biconvex) Size22mm\n\n\nFlavorImprint Code\n                           \n                           I07\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score 2 pieces Shape CAPSULE (biconvex)  Size 22mm Flavor  Imprint Code \n                           \n                           I07\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score 2 pieces\nShape CAPSULE (biconvex)  Size 22mm\nFlavor  Imprint Code \n                           \n                           I07\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-162-4220  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-162-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-162-444  in 1 CARTON03/01/2017\n\n\n3NDC:42571-162-434  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-162-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-162-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-162-44 4  in 1 CARTON 03/01/2017  3 NDC:42571-162-43 4  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-162-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-162-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-162-44 4  in 1 CARTON 03/01/2017 \n3 NDC:42571-162-43 4  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20475503/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204755 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204755 03/01/2017 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  867064609 analysis(42571-160, 42571-161, 42571-162) , label(42571-160, 42571-161, 42571-162) , manufacture(42571-160, 42571-161, 42571-162) , pack(42571-160, 42571-161, 42571-162) \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-160\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-160 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-160\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS250\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeCAPSULE (biconvex) Size17mm\n\n\nFlavorImprint Code\n                           \n                           I05\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape CAPSULE (biconvex)  Size 17mm Flavor  Imprint Code \n                           \n                           I05\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape CAPSULE (biconvex)  Size 17mm\nFlavor  Imprint Code \n                           \n                           I05\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-160-3030  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-160-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-160-1110  in 1 CARTON03/01/2017\n\n\n3NDC:42571-160-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-160-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-160-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-160-11 10  in 1 CARTON 03/01/2017  3 NDC:42571-160-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-160-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-160-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-160-11 10  in 1 CARTON 03/01/2017 \n3 NDC:42571-160-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20570703/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205707 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205707 03/01/2017 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-161\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-161 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-161\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS500\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeCAPSULE (biconvex) Size19mm\n\n\nFlavorImprint Code\n                           \n                           I06\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape CAPSULE (biconvex)  Size 19mm Flavor  Imprint Code \n                           \n                           I06\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape CAPSULE (biconvex)  Size 19mm\nFlavor  Imprint Code \n                           \n                           I06\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-161-4220  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-161-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-161-1110  in 1 CARTON03/01/2017\n\n\n3NDC:42571-161-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-161-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-161-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-161-11 10  in 1 CARTON 03/01/2017  3 NDC:42571-161-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-161-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-161-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-161-11 10  in 1 CARTON 03/01/2017 \n3 NDC:42571-161-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20570703/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205707 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205707 03/01/2017 \nAMOXICILLIN AND CLAVULANATE POTASSIUM\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin and clavulanate potassium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-162\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-162 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-162\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS875\u00a0mg\n\n\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24) CLAVULANIC ACID125\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 875\u00a0mg CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 875\u00a0mg\nCLAVULANATE POTASSIUM (UNII: Q42OMW3AT8)  (CLAVULANIC ACID - UNII:23521W1S24)  CLAVULANIC ACID 125\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4) \u00a0\n\n\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0 HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 ETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSILICON DIOXIDE (UNII: ETJ7Z6XBU4)  \u00a0\nHYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nMICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nSODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nETHYLCELLULOSE (10 MPA.S) (UNII: 3DYK7UYZ62)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Score2 pieces\n\n\nShapeCAPSULE (biconvex) Size22mm\n\n\nFlavorImprint Code\n                           \n                           I07\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score 2 pieces Shape CAPSULE (biconvex)  Size 22mm Flavor  Imprint Code \n                           \n                           I07\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score 2 pieces\nShape CAPSULE (biconvex)  Size 22mm\nFlavor  Imprint Code \n                           \n                           I07\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-162-4220  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n2NDC:42571-162-01100  in 1 BOTTLE; Type 0: Not a Combination Product03/01/2017\n\n\n3NDC:42571-162-444  in 1 CARTON03/01/2017\n\n\n3NDC:42571-162-434  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-162-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  2 NDC:42571-162-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017  3 NDC:42571-162-44 4  in 1 CARTON 03/01/2017  3 NDC:42571-162-43 4  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-162-42 20  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n2 NDC:42571-162-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 03/01/2017 \n3 NDC:42571-162-44 4  in 1 CARTON 03/01/2017 \n3 NDC:42571-162-43 4  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20475503/01/2017\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204755 03/01/2017 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204755 03/01/2017 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  867064609 analysis(42571-160, 42571-161, 42571-162) , label(42571-160, 42571-161, 42571-162) , manufacture(42571-160, 42571-161, 42571-162) , pack(42571-160, 42571-161, 42571-162)",
    "dosage": null,
    "contraindications": null,
    "side_effects": null,
    "warnings": null
  },
  {
    "product_name": "Amoxicillin Capsules, USP",
    "INGREDIENTS AND APPEARANCE": "AMOXICILLIN\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-233\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-233 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-233\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS250\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SHELLAC (UNII: 46N107B71O)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSHELLAC (UNII: 46N107B71O)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white opaque) Scoreno score\n\n\nShapeCAPSULE (capsule) Size18mm\n\n\nFlavorImprint Code\n                           \n                           M;33\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white opaque)  Score no score Shape CAPSULE (capsule)  Size 18mm Flavor  Imprint Code \n                           \n                           M;33\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white opaque)  Score no score\nShape CAPSULE (capsule)  Size 18mm\nFlavor  Imprint Code \n                           \n                           M;33\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-233-3030  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n2NDC:42571-233-01100  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n3NDC:42571-233-05500  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n4NDC:42571-233-101000  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-233-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  2 NDC:42571-233-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  3 NDC:42571-233-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  4 NDC:42571-233-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-233-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n2 NDC:42571-233-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n3 NDC:42571-233-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n4 NDC:42571-233-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20747111/01/2022\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207471 11/01/2022 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207471 11/01/2022 \nAMOXICILLIN\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-234\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-234 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-234\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS500\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white opaque) Scoreno score\n\n\nShapeCAPSULE (capsule) Size21mm\n\n\nFlavorImprint Code\n                           \n                           M;34\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white opaque)  Score no score Shape CAPSULE (capsule)  Size 21mm Flavor  Imprint Code \n                           \n                           M;34\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white opaque)  Score no score\nShape CAPSULE (capsule)  Size 21mm\nFlavor  Imprint Code \n                           \n                           M;34\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-234-3030  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n2NDC:42571-234-01100  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n3NDC:42571-234-05500  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n4NDC:42571-234-101000  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-234-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  2 NDC:42571-234-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  3 NDC:42571-234-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  4 NDC:42571-234-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-234-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n2 NDC:42571-234-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n3 NDC:42571-234-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n4 NDC:42571-234-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20747111/01/2022\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207471 11/01/2022 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207471 11/01/2022 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  867064609 analysis(42571-233, 42571-234) , label(42571-233, 42571-234) , manufacture(42571-233, 42571-234) , pack(42571-233, 42571-234) \nAMOXICILLIN\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-233\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-233 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-233\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS250\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SHELLAC (UNII: 46N107B71O)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSHELLAC (UNII: 46N107B71O)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white opaque) Scoreno score\n\n\nShapeCAPSULE (capsule) Size18mm\n\n\nFlavorImprint Code\n                           \n                           M;33\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white opaque)  Score no score Shape CAPSULE (capsule)  Size 18mm Flavor  Imprint Code \n                           \n                           M;33\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white opaque)  Score no score\nShape CAPSULE (capsule)  Size 18mm\nFlavor  Imprint Code \n                           \n                           M;33\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-233-3030  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n2NDC:42571-233-01100  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n3NDC:42571-233-05500  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n4NDC:42571-233-101000  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-233-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  2 NDC:42571-233-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  3 NDC:42571-233-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  4 NDC:42571-233-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-233-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n2 NDC:42571-233-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n3 NDC:42571-233-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n4 NDC:42571-233-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20747111/01/2022\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207471 11/01/2022 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207471 11/01/2022 \nAMOXICILLIN\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-234\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-234 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-234\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS500\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white opaque) Scoreno score\n\n\nShapeCAPSULE (capsule) Size21mm\n\n\nFlavorImprint Code\n                           \n                           M;34\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white opaque)  Score no score Shape CAPSULE (capsule)  Size 21mm Flavor  Imprint Code \n                           \n                           M;34\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white opaque)  Score no score\nShape CAPSULE (capsule)  Size 21mm\nFlavor  Imprint Code \n                           \n                           M;34\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-234-3030  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n2NDC:42571-234-01100  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n3NDC:42571-234-05500  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n4NDC:42571-234-101000  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-234-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  2 NDC:42571-234-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  3 NDC:42571-234-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  4 NDC:42571-234-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-234-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n2 NDC:42571-234-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n3 NDC:42571-234-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n4 NDC:42571-234-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20747111/01/2022\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207471 11/01/2022 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207471 11/01/2022 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  867064609 analysis(42571-233, 42571-234) , label(42571-233, 42571-234) , manufacture(42571-233, 42571-234) , pack(42571-233, 42571-234) \nAMOXICILLIN\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-233\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-233 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-233\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS250\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SHELLAC (UNII: 46N107B71O)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSHELLAC (UNII: 46N107B71O)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white opaque) Scoreno score\n\n\nShapeCAPSULE (capsule) Size18mm\n\n\nFlavorImprint Code\n                           \n                           M;33\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white opaque)  Score no score Shape CAPSULE (capsule)  Size 18mm Flavor  Imprint Code \n                           \n                           M;33\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white opaque)  Score no score\nShape CAPSULE (capsule)  Size 18mm\nFlavor  Imprint Code \n                           \n                           M;33\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-233-3030  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n2NDC:42571-233-01100  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n3NDC:42571-233-05500  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n4NDC:42571-233-101000  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-233-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  2 NDC:42571-233-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  3 NDC:42571-233-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  4 NDC:42571-233-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-233-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n2 NDC:42571-233-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n3 NDC:42571-233-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n4 NDC:42571-233-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20747111/01/2022\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207471 11/01/2022 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207471 11/01/2022 \nAMOXICILLIN\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-234\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-234 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-234\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS500\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white opaque) Scoreno score\n\n\nShapeCAPSULE (capsule) Size21mm\n\n\nFlavorImprint Code\n                           \n                           M;34\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white opaque)  Score no score Shape CAPSULE (capsule)  Size 21mm Flavor  Imprint Code \n                           \n                           M;34\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white opaque)  Score no score\nShape CAPSULE (capsule)  Size 21mm\nFlavor  Imprint Code \n                           \n                           M;34\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-234-3030  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n2NDC:42571-234-01100  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n3NDC:42571-234-05500  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n4NDC:42571-234-101000  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-234-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  2 NDC:42571-234-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  3 NDC:42571-234-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  4 NDC:42571-234-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-234-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n2 NDC:42571-234-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n3 NDC:42571-234-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n4 NDC:42571-234-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20747111/01/2022\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207471 11/01/2022 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207471 11/01/2022 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  867064609 analysis(42571-233, 42571-234) , label(42571-233, 42571-234) , manufacture(42571-233, 42571-234) , pack(42571-233, 42571-234) \nAMOXICILLIN\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-233\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-233 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-233\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS250\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 250\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SHELLAC (UNII: 46N107B71O)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSHELLAC (UNII: 46N107B71O)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white opaque) Scoreno score\n\n\nShapeCAPSULE (capsule) Size18mm\n\n\nFlavorImprint Code\n                           \n                           M;33\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white opaque)  Score no score Shape CAPSULE (capsule)  Size 18mm Flavor  Imprint Code \n                           \n                           M;33\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white opaque)  Score no score\nShape CAPSULE (capsule)  Size 18mm\nFlavor  Imprint Code \n                           \n                           M;33\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-233-3030  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n2NDC:42571-233-01100  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n3NDC:42571-233-05500  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n4NDC:42571-233-101000  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-233-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  2 NDC:42571-233-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  3 NDC:42571-233-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  4 NDC:42571-233-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-233-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n2 NDC:42571-233-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n3 NDC:42571-233-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n4 NDC:42571-233-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20747111/01/2022\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207471 11/01/2022 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207471 11/01/2022 \nAMOXICILLIN\n\u00a0\t\t\n\t\t\t\t\t\n\namoxicillin capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-234\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-234 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-234\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS500\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nAMOXICILLIN (UNII: 804826J2HU)  (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)  AMOXICILLIN ANHYDROUS 500\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white opaque) Scoreno score\n\n\nShapeCAPSULE (capsule) Size21mm\n\n\nFlavorImprint Code\n                           \n                           M;34\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white opaque)  Score no score Shape CAPSULE (capsule)  Size 21mm Flavor  Imprint Code \n                           \n                           M;34\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white opaque)  Score no score\nShape CAPSULE (capsule)  Size 21mm\nFlavor  Imprint Code \n                           \n                           M;34\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-234-3030  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n2NDC:42571-234-01100  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n3NDC:42571-234-05500  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n4NDC:42571-234-101000  in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-234-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  2 NDC:42571-234-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  3 NDC:42571-234-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022  4 NDC:42571-234-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-234-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n2 NDC:42571-234-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n3 NDC:42571-234-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n4 NDC:42571-234-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2022 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20747111/01/2022\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207471 11/01/2022 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA207471 11/01/2022 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  867064609 analysis(42571-233, 42571-234) , label(42571-233, 42571-234) , manufacture(42571-233, 42571-234) , pack(42571-233, 42571-234)",
    "dosage": null,
    "contraindications": null,
    "side_effects": null,
    "warnings": null
  },
  {
    "product_name": "Aspirin and Extended-Release Dipyridamole Capsules",
    "INGREDIENTS AND APPEARANCE": "ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE\u00a0\t\t\n\t\t\t\t\t\n\naspirin and extended-release dipyridamole capsule, extended release\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-274\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-274 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-274\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nASPIRIN (UNII: R16CO5Y76E)  (ASPIRIN - UNII:R16CO5Y76E) ASPIRIN25\u00a0mg\n\n\nDIPYRIDAMOLE (UNII: 64ALC7F90C)  (DIPYRIDAMOLE - UNII:64ALC7F90C) DIPYRIDAMOLE200\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ASPIRIN (UNII: R16CO5Y76E)  (ASPIRIN - UNII:R16CO5Y76E)  ASPIRIN 25\u00a0mg DIPYRIDAMOLE (UNII: 64ALC7F90C)  (DIPYRIDAMOLE - UNII:64ALC7F90C)  DIPYRIDAMOLE 200\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nASPIRIN (UNII: R16CO5Y76E)  (ASPIRIN - UNII:R16CO5Y76E)  ASPIRIN 25\u00a0mg\nDIPYRIDAMOLE (UNII: 64ALC7F90C)  (DIPYRIDAMOLE - UNII:64ALC7F90C)  DIPYRIDAMOLE 200\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCAPRYLIC/CAPRIC MONO/DIGLYCERIDES (UNII: U72Q2I8C85) \u00a0\n\n\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFD&C BLUE NO. 1 (UNII: H3R47K3TBD) \u00a0\n\n\nGLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) \u00a0\n\n\nHYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6) \u00a0\n\n\nMETHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTARTARIC ACID (UNII: W4888I119H) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nTRIACETIN (UNII: XHX3C3X673) \u00a0\n\n\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nSHELLAC (UNII: MB5IUD6JUA) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CAPRYLIC/CAPRIC MONO/DIGLYCERIDES (UNII: U72Q2I8C85)  \u00a0 D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  \u00a0 GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  \u00a0 HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  \u00a0 METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TARTARIC ACID (UNII: W4888I119H)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 TRIACETIN (UNII: XHX3C3X673)  \u00a0 TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 SHELLAC (UNII: MB5IUD6JUA)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCAPRYLIC/CAPRIC MONO/DIGLYCERIDES (UNII: U72Q2I8C85)  \u00a0\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFD&C BLUE NO. 1 (UNII: H3R47K3TBD)  \u00a0\nGLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  \u00a0\nHYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  \u00a0\nMETHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTARTARIC ACID (UNII: W4888I119H)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nTRIACETIN (UNII: XHX3C3X673)  \u00a0\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nSHELLAC (UNII: MB5IUD6JUA)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorred (red opaque colored cap and ivory opaque colored body) Scoreno score\n\n\nShapeCAPSULE (capsule) Size24mm\n\n\nFlavorImprint Code\n                           \n                           M25\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color red (red opaque colored cap and ivory opaque colored body)  Score no score Shape CAPSULE (capsule)  Size 24mm Flavor  Imprint Code \n                           \n                           M25\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor red (red opaque colored cap and ivory opaque colored body)  Score no score\nShape CAPSULE (capsule)  Size 24mm\nFlavor  Imprint Code \n                           \n                           M25\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-274-6060  in 1 BOTTLE; Type 0: Not a Combination Product08/16/2021\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-274-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 08/16/2021 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-274-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 08/16/2021 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20992908/16/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA209929 08/16/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA209929 08/16/2021 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-274) , label(42571-274) , manufacture(42571-274) , pack(42571-274) \nASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE\u00a0\t\t\n\t\t\t\t\t\n\naspirin and extended-release dipyridamole capsule, extended release\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-274\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-274 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-274\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nASPIRIN (UNII: R16CO5Y76E)  (ASPIRIN - UNII:R16CO5Y76E) ASPIRIN25\u00a0mg\n\n\nDIPYRIDAMOLE (UNII: 64ALC7F90C)  (DIPYRIDAMOLE - UNII:64ALC7F90C) DIPYRIDAMOLE200\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ASPIRIN (UNII: R16CO5Y76E)  (ASPIRIN - UNII:R16CO5Y76E)  ASPIRIN 25\u00a0mg DIPYRIDAMOLE (UNII: 64ALC7F90C)  (DIPYRIDAMOLE - UNII:64ALC7F90C)  DIPYRIDAMOLE 200\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nASPIRIN (UNII: R16CO5Y76E)  (ASPIRIN - UNII:R16CO5Y76E)  ASPIRIN 25\u00a0mg\nDIPYRIDAMOLE (UNII: 64ALC7F90C)  (DIPYRIDAMOLE - UNII:64ALC7F90C)  DIPYRIDAMOLE 200\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCAPRYLIC/CAPRIC MONO/DIGLYCERIDES (UNII: U72Q2I8C85) \u00a0\n\n\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFD&C BLUE NO. 1 (UNII: H3R47K3TBD) \u00a0\n\n\nGLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) \u00a0\n\n\nHYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6) \u00a0\n\n\nMETHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTARTARIC ACID (UNII: W4888I119H) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nTRIACETIN (UNII: XHX3C3X673) \u00a0\n\n\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nSHELLAC (UNII: MB5IUD6JUA) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CAPRYLIC/CAPRIC MONO/DIGLYCERIDES (UNII: U72Q2I8C85)  \u00a0 D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  \u00a0 GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  \u00a0 HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  \u00a0 METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TARTARIC ACID (UNII: W4888I119H)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 TRIACETIN (UNII: XHX3C3X673)  \u00a0 TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 SHELLAC (UNII: MB5IUD6JUA)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCAPRYLIC/CAPRIC MONO/DIGLYCERIDES (UNII: U72Q2I8C85)  \u00a0\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFD&C BLUE NO. 1 (UNII: H3R47K3TBD)  \u00a0\nGLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  \u00a0\nHYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  \u00a0\nMETHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTARTARIC ACID (UNII: W4888I119H)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nTRIACETIN (UNII: XHX3C3X673)  \u00a0\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nSHELLAC (UNII: MB5IUD6JUA)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorred (red opaque colored cap and ivory opaque colored body) Scoreno score\n\n\nShapeCAPSULE (capsule) Size24mm\n\n\nFlavorImprint Code\n                           \n                           M25\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color red (red opaque colored cap and ivory opaque colored body)  Score no score Shape CAPSULE (capsule)  Size 24mm Flavor  Imprint Code \n                           \n                           M25\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor red (red opaque colored cap and ivory opaque colored body)  Score no score\nShape CAPSULE (capsule)  Size 24mm\nFlavor  Imprint Code \n                           \n                           M25\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-274-6060  in 1 BOTTLE; Type 0: Not a Combination Product08/16/2021\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-274-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 08/16/2021 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-274-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 08/16/2021 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20992908/16/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA209929 08/16/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA209929 08/16/2021 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-274) , label(42571-274) , manufacture(42571-274) , pack(42571-274) \nASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE\u00a0\t\t\n\t\t\t\t\t\n\naspirin and extended-release dipyridamole capsule, extended release\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-274\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-274 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-274\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nASPIRIN (UNII: R16CO5Y76E)  (ASPIRIN - UNII:R16CO5Y76E) ASPIRIN25\u00a0mg\n\n\nDIPYRIDAMOLE (UNII: 64ALC7F90C)  (DIPYRIDAMOLE - UNII:64ALC7F90C) DIPYRIDAMOLE200\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ASPIRIN (UNII: R16CO5Y76E)  (ASPIRIN - UNII:R16CO5Y76E)  ASPIRIN 25\u00a0mg DIPYRIDAMOLE (UNII: 64ALC7F90C)  (DIPYRIDAMOLE - UNII:64ALC7F90C)  DIPYRIDAMOLE 200\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nASPIRIN (UNII: R16CO5Y76E)  (ASPIRIN - UNII:R16CO5Y76E)  ASPIRIN 25\u00a0mg\nDIPYRIDAMOLE (UNII: 64ALC7F90C)  (DIPYRIDAMOLE - UNII:64ALC7F90C)  DIPYRIDAMOLE 200\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCAPRYLIC/CAPRIC MONO/DIGLYCERIDES (UNII: U72Q2I8C85) \u00a0\n\n\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G) \u00a0\n\n\nFERRIC OXIDE RED (UNII: 1K09F3G675) \u00a0\n\n\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT) \u00a0\n\n\nFD&C BLUE NO. 1 (UNII: H3R47K3TBD) \u00a0\n\n\nGLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) \u00a0\n\n\nHYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6) \u00a0\n\n\nMETHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTARTARIC ACID (UNII: W4888I119H) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nTRIACETIN (UNII: XHX3C3X673) \u00a0\n\n\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nSHELLAC (UNII: MB5IUD6JUA) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPOLYVINYL ALCOHOL (UNII: 532B59J990) \u00a0\n\n\nAMMONIA (UNII: 5138Q19F1X) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CAPRYLIC/CAPRIC MONO/DIGLYCERIDES (UNII: U72Q2I8C85)  \u00a0 D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0 FERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0 FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0 FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  \u00a0 GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  \u00a0 HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  \u00a0 METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TARTARIC ACID (UNII: W4888I119H)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 TRIACETIN (UNII: XHX3C3X673)  \u00a0 TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 SHELLAC (UNII: MB5IUD6JUA)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 POLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0 AMMONIA (UNII: 5138Q19F1X)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCAPRYLIC/CAPRIC MONO/DIGLYCERIDES (UNII: U72Q2I8C85)  \u00a0\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0\nFERRIC OXIDE RED (UNII: 1K09F3G675)  \u00a0\nFERRIC OXIDE YELLOW (UNII: EX438O2MRT)  \u00a0\nFD&C BLUE NO. 1 (UNII: H3R47K3TBD)  \u00a0\nGLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  \u00a0\nHYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  \u00a0\nMETHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTARTARIC ACID (UNII: W4888I119H)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nTRIACETIN (UNII: XHX3C3X673)  \u00a0\nTRIETHYL CITRATE (UNII: 8Z96QXD6UM)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nSHELLAC (UNII: MB5IUD6JUA)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPOLYVINYL ALCOHOL (UNII: 532B59J990)  \u00a0\nAMMONIA (UNII: 5138Q19F1X)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorred (red opaque colored cap and ivory opaque colored body) Scoreno score\n\n\nShapeCAPSULE (capsule) Size24mm\n\n\nFlavorImprint Code\n                           \n                           M25\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color red (red opaque colored cap and ivory opaque colored body)  Score no score Shape CAPSULE (capsule)  Size 24mm Flavor  Imprint Code \n                           \n                           M25\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor red (red opaque colored cap and ivory opaque colored body)  Score no score\nShape CAPSULE (capsule)  Size 24mm\nFlavor  Imprint Code \n                           \n                           M25\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-274-6060  in 1 BOTTLE; Type 0: Not a Combination Product08/16/2021\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-274-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 08/16/2021 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-274-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 08/16/2021 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20992908/16/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA209929 08/16/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA209929 08/16/2021 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-274) , label(42571-274) , manufacture(42571-274) , pack(42571-274)",
    "dosage": null,
    "contraindications": null,
    "side_effects": null,
    "warnings": null
  },
  {
    "product_name": "Atorvastatin Calcium Tablets",
    "INGREDIENTS AND APPEARANCE": "ATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-172\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-172 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-172\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN10\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 10\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 10\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize10mm\n\n\nFlavorImprint Code\n                           \n                           I;90\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 10mm Flavor  Imprint Code \n                           \n                           I;90\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 10mm\nFlavor  Imprint Code \n                           \n                           I;90\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-172-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-172-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-172-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-172-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-172-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-172-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-172-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-172-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-172-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-172-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-172-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-172-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-172-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-172-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-172-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-173\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-173 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-173\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize12mm\n\n\nFlavorImprint Code\n                           \n                           I;91\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 12mm Flavor  Imprint Code \n                           \n                           I;91\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 12mm\nFlavor  Imprint Code \n                           \n                           I;91\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-173-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-173-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-173-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-173-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-173-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-173-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-173-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-173-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-173-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-173-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-173-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-173-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-173-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-173-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-173-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-174\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-174 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-174\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize15mm\n\n\nFlavorImprint Code\n                           \n                           I;92\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 15mm Flavor  Imprint Code \n                           \n                           I;92\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 15mm\nFlavor  Imprint Code \n                           \n                           I;92\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-174-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-174-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-174-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-174-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-174-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-174-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-174-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-174-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-174-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-174-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-174-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-174-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-174-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-174-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-174-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-175\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-175 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-175\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN80\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 80\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 80\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize19mm\n\n\nFlavorImprint Code\n                           \n                           I;93\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 19mm Flavor  Imprint Code \n                           \n                           I;93\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 19mm\nFlavor  Imprint Code \n                           \n                           I;93\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-175-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-175-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-175-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-175-245  in 1 CARTON01/01/2020\n\n\n4NDC:42571-175-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-175-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-175-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-175-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-175-24 5  in 1 CARTON 01/01/2020  4 NDC:42571-175-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-175-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-175-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-175-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-175-24 5  in 1 CARTON 01/01/2020 \n4 NDC:42571-175-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-172, 42571-173, 42571-174, 42571-175) , label(42571-172, 42571-173, 42571-174, 42571-175) , manufacture(42571-172, 42571-173, 42571-174, 42571-175) , pack(42571-172, 42571-173, 42571-174, 42571-175) \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-172\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-172 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-172\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN10\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 10\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 10\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize10mm\n\n\nFlavorImprint Code\n                           \n                           I;90\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 10mm Flavor  Imprint Code \n                           \n                           I;90\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 10mm\nFlavor  Imprint Code \n                           \n                           I;90\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-172-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-172-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-172-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-172-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-172-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-172-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-172-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-172-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-172-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-172-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-172-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-172-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-172-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-172-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-172-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-173\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-173 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-173\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize12mm\n\n\nFlavorImprint Code\n                           \n                           I;91\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 12mm Flavor  Imprint Code \n                           \n                           I;91\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 12mm\nFlavor  Imprint Code \n                           \n                           I;91\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-173-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-173-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-173-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-173-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-173-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-173-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-173-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-173-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-173-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-173-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-173-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-173-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-173-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-173-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-173-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-174\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-174 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-174\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize15mm\n\n\nFlavorImprint Code\n                           \n                           I;92\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 15mm Flavor  Imprint Code \n                           \n                           I;92\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 15mm\nFlavor  Imprint Code \n                           \n                           I;92\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-174-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-174-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-174-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-174-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-174-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-174-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-174-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-174-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-174-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-174-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-174-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-174-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-174-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-174-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-174-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-175\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-175 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-175\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN80\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 80\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 80\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize19mm\n\n\nFlavorImprint Code\n                           \n                           I;93\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 19mm Flavor  Imprint Code \n                           \n                           I;93\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 19mm\nFlavor  Imprint Code \n                           \n                           I;93\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-175-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-175-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-175-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-175-245  in 1 CARTON01/01/2020\n\n\n4NDC:42571-175-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-175-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-175-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-175-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-175-24 5  in 1 CARTON 01/01/2020  4 NDC:42571-175-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-175-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-175-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-175-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-175-24 5  in 1 CARTON 01/01/2020 \n4 NDC:42571-175-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-172, 42571-173, 42571-174, 42571-175) , label(42571-172, 42571-173, 42571-174, 42571-175) , manufacture(42571-172, 42571-173, 42571-174, 42571-175) , pack(42571-172, 42571-173, 42571-174, 42571-175) \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-172\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-172 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-172\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN10\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 10\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 10\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize10mm\n\n\nFlavorImprint Code\n                           \n                           I;90\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 10mm Flavor  Imprint Code \n                           \n                           I;90\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 10mm\nFlavor  Imprint Code \n                           \n                           I;90\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-172-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-172-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-172-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-172-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-172-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-172-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-172-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-172-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-172-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-172-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-172-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-172-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-172-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-172-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-172-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-173\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-173 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-173\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize12mm\n\n\nFlavorImprint Code\n                           \n                           I;91\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 12mm Flavor  Imprint Code \n                           \n                           I;91\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 12mm\nFlavor  Imprint Code \n                           \n                           I;91\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-173-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-173-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-173-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-173-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-173-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-173-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-173-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-173-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-173-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-173-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-173-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-173-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-173-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-173-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-173-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-174\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-174 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-174\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize15mm\n\n\nFlavorImprint Code\n                           \n                           I;92\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 15mm Flavor  Imprint Code \n                           \n                           I;92\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 15mm\nFlavor  Imprint Code \n                           \n                           I;92\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-174-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-174-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-174-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-174-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-174-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-174-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-174-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-174-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-174-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-174-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-174-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-174-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-174-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-174-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-174-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-175\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-175 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-175\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN80\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 80\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 80\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize19mm\n\n\nFlavorImprint Code\n                           \n                           I;93\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 19mm Flavor  Imprint Code \n                           \n                           I;93\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 19mm\nFlavor  Imprint Code \n                           \n                           I;93\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-175-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-175-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-175-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-175-245  in 1 CARTON01/01/2020\n\n\n4NDC:42571-175-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-175-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-175-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-175-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-175-24 5  in 1 CARTON 01/01/2020  4 NDC:42571-175-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-175-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-175-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-175-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-175-24 5  in 1 CARTON 01/01/2020 \n4 NDC:42571-175-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-172, 42571-173, 42571-174, 42571-175) , label(42571-172, 42571-173, 42571-174, 42571-175) , manufacture(42571-172, 42571-173, 42571-174, 42571-175) , pack(42571-172, 42571-173, 42571-174, 42571-175) \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-172\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-172 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-172\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN10\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 10\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 10\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize10mm\n\n\nFlavorImprint Code\n                           \n                           I;90\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 10mm Flavor  Imprint Code \n                           \n                           I;90\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 10mm\nFlavor  Imprint Code \n                           \n                           I;90\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-172-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-172-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-172-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-172-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-172-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-172-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-172-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-172-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-172-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-172-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-172-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-172-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-172-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-172-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-172-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-173\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-173 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-173\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize12mm\n\n\nFlavorImprint Code\n                           \n                           I;91\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 12mm Flavor  Imprint Code \n                           \n                           I;91\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 12mm\nFlavor  Imprint Code \n                           \n                           I;91\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-173-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-173-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-173-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-173-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-173-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-173-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-173-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-173-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-173-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-173-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-173-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-173-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-173-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-173-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-173-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-174\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-174 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-174\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize15mm\n\n\nFlavorImprint Code\n                           \n                           I;92\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 15mm Flavor  Imprint Code \n                           \n                           I;92\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 15mm\nFlavor  Imprint Code \n                           \n                           I;92\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-174-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-174-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-174-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-174-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-174-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-174-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-174-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-174-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-174-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-174-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-174-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-174-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-174-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-174-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-174-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-175\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-175 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-175\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN80\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 80\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 80\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize19mm\n\n\nFlavorImprint Code\n                           \n                           I;93\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 19mm Flavor  Imprint Code \n                           \n                           I;93\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 19mm\nFlavor  Imprint Code \n                           \n                           I;93\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-175-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-175-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-175-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-175-245  in 1 CARTON01/01/2020\n\n\n4NDC:42571-175-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-175-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-175-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-175-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-175-24 5  in 1 CARTON 01/01/2020  4 NDC:42571-175-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-175-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-175-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-175-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-175-24 5  in 1 CARTON 01/01/2020 \n4 NDC:42571-175-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-172, 42571-173, 42571-174, 42571-175) , label(42571-172, 42571-173, 42571-174, 42571-175) , manufacture(42571-172, 42571-173, 42571-174, 42571-175) , pack(42571-172, 42571-173, 42571-174, 42571-175) \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-172\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-172 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-172\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN10\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 10\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 10\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize10mm\n\n\nFlavorImprint Code\n                           \n                           I;90\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 10mm Flavor  Imprint Code \n                           \n                           I;90\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 10mm\nFlavor  Imprint Code \n                           \n                           I;90\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-172-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-172-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-172-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-172-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-172-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-172-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-172-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-172-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-172-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-172-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-172-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-172-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-172-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-172-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-172-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-173\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-173 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-173\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize12mm\n\n\nFlavorImprint Code\n                           \n                           I;91\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 12mm Flavor  Imprint Code \n                           \n                           I;91\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 12mm\nFlavor  Imprint Code \n                           \n                           I;91\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-173-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-173-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-173-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-173-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-173-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-173-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-173-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-173-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-173-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-173-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-173-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-173-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-173-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-173-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-173-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-174\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-174 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-174\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize15mm\n\n\nFlavorImprint Code\n                           \n                           I;92\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 15mm Flavor  Imprint Code \n                           \n                           I;92\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 15mm\nFlavor  Imprint Code \n                           \n                           I;92\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-174-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-174-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-174-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-174-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-174-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-174-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-174-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-174-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-174-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-174-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-174-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-174-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-174-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-174-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-174-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-175\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-175 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-175\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN80\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 80\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 80\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize19mm\n\n\nFlavorImprint Code\n                           \n                           I;93\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 19mm Flavor  Imprint Code \n                           \n                           I;93\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 19mm\nFlavor  Imprint Code \n                           \n                           I;93\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-175-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-175-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-175-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-175-245  in 1 CARTON01/01/2020\n\n\n4NDC:42571-175-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-175-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-175-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-175-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-175-24 5  in 1 CARTON 01/01/2020  4 NDC:42571-175-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-175-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-175-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-175-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-175-24 5  in 1 CARTON 01/01/2020 \n4 NDC:42571-175-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-172, 42571-173, 42571-174, 42571-175) , label(42571-172, 42571-173, 42571-174, 42571-175) , manufacture(42571-172, 42571-173, 42571-174, 42571-175) , pack(42571-172, 42571-173, 42571-174, 42571-175) \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-172\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-172 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-172\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN10\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 10\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 10\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize10mm\n\n\nFlavorImprint Code\n                           \n                           I;90\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 10mm Flavor  Imprint Code \n                           \n                           I;90\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 10mm\nFlavor  Imprint Code \n                           \n                           I;90\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-172-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-172-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-172-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-172-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-172-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-172-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-172-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-172-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-172-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-172-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-172-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-172-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-172-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-172-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-172-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-173\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-173 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-173\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN20\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 20\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 20\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize12mm\n\n\nFlavorImprint Code\n                           \n                           I;91\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 12mm Flavor  Imprint Code \n                           \n                           I;91\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 12mm\nFlavor  Imprint Code \n                           \n                           I;91\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-173-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-173-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-173-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-173-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-173-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-173-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-173-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-173-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-173-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-173-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-173-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-173-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-173-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-173-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-173-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-174\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-174 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-174\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN40\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 40\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 40\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize15mm\n\n\nFlavorImprint Code\n                           \n                           I;92\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 15mm Flavor  Imprint Code \n                           \n                           I;92\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 15mm\nFlavor  Imprint Code \n                           \n                           I;92\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-174-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-174-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-174-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-174-1110  in 1 CARTON01/01/2020\n\n\n4NDC:42571-174-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-174-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-174-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-174-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-174-11 10  in 1 CARTON 01/01/2020  4 NDC:42571-174-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-174-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-174-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-174-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-174-11 10  in 1 CARTON 01/01/2020 \n4 NDC:42571-174-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nATORVASTATIN CALCIUM\n\u00a0\t\t\n\t\t\t\t\t\n\natorvastatin calcium tablet, film coated\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-175\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-175 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-175\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F) ATORVASTATIN80\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 80\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nATORVASTATIN CALCIUM TRIHYDRATE (UNII: 48A5M73Z4Q)  (ATORVASTATIN - UNII:A0JWA85V8F)  ATORVASTATIN 80\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCALCIUM CARBONATE (UNII: H0G9379FGK) \u00a0\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) \u00a0\n\n\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H) \u00a0\n\n\nHYPROMELLOSES (UNII: 3NXW29V3WO) \u00a0\n\n\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0 CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0 POLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0 HYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0 POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCALCIUM CARBONATE (UNII: H0G9379FGK)  \u00a0\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nHYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nCELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  \u00a0\nPOLYSORBATE 80 (UNII: 6OZP39ZG8H)  \u00a0\nHYPROMELLOSES (UNII: 3NXW29V3WO)  \u00a0\nPOLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white to off-white) Scoreno score\n\n\nShapeOVALSize19mm\n\n\nFlavorImprint Code\n                           \n                           I;93\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white to off-white)  Score no score Shape OVAL Size 19mm Flavor  Imprint Code \n                           \n                           I;93\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white to off-white)  Score no score\nShape OVAL Size 19mm\nFlavor  Imprint Code \n                           \n                           I;93\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-175-3030  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n2NDC:42571-175-9090  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n3NDC:42571-175-101000  in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020\n\n\n4NDC:42571-175-245  in 1 CARTON01/01/2020\n\n\n4NDC:42571-175-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-175-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  2 NDC:42571-175-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  3 NDC:42571-175-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020  4 NDC:42571-175-24 5  in 1 CARTON 01/01/2020  4 NDC:42571-175-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-175-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n2 NDC:42571-175-90 90  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n3 NDC:42571-175-10 1000  in 1 BOTTLE; Type 0: Not a Combination Product 01/01/2020 \n4 NDC:42571-175-24 5  in 1 CARTON 01/01/2020 \n4 NDC:42571-175-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20594501/01/2020\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA205945 01/01/2020 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA205945 01/01/2020 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-172, 42571-173, 42571-174, 42571-175) , label(42571-172, 42571-173, 42571-174, 42571-175) , manufacture(42571-172, 42571-173, 42571-174, 42571-175) , pack(42571-172, 42571-173, 42571-174, 42571-175)",
    "dosage": null,
    "contraindications": null,
    "side_effects": null,
    "warnings": null
  },
  {
    "product_name": "Bimatoprost Ophthalmic Solution",
    "INGREDIENTS AND APPEARANCE": "BIMATOPROST\n\u00a0\t\t\n\t\t\t\t\t\n\nbimatoprost solution/ drops\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-128\n\n\nRoute of AdministrationOPHTHALMIC\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-128 Route of Administration OPHTHALMIC\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-128\nRoute of Administration OPHTHALMIC\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nBIMATOPROST (UNII: QXS94885MZ)  (BIMATOPROST - UNII:QXS94885MZ) BIMATOPROST0.3\u00a0mg \u00a0in\u00a01\u00a0mL\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BIMATOPROST (UNII: QXS94885MZ)  (BIMATOPROST - UNII:QXS94885MZ)  BIMATOPROST 0.3\u00a0mg \u00a0in\u00a01\u00a0mL\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nBIMATOPROST (UNII: QXS94885MZ)  (BIMATOPROST - UNII:QXS94885MZ)  BIMATOPROST 0.3\u00a0mg \u00a0in\u00a01\u00a0mL\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSODIUM CHLORIDE (UNII: 451W47IQ8X) \u00a0\n\n\nSODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE (UNII: 70WT22SF4B) \u00a0\n\n\nCITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) \u00a0\n\n\nWATER (UNII: 059QF0KO0R) \u00a0\n\n\nSODIUM HYDROXIDE (UNII: 55X04QC32I) \u00a0\n\n\nHYDROCHLORIC ACID (UNII: QTT17582CB) \u00a0\n\n\nBENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SODIUM CHLORIDE (UNII: 451W47IQ8X)  \u00a0 SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE (UNII: 70WT22SF4B)  \u00a0 CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  \u00a0 WATER (UNII: 059QF0KO0R)  \u00a0 SODIUM HYDROXIDE (UNII: 55X04QC32I)  \u00a0 HYDROCHLORIC ACID (UNII: QTT17582CB)  \u00a0 BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSODIUM CHLORIDE (UNII: 451W47IQ8X)  \u00a0\nSODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE (UNII: 70WT22SF4B)  \u00a0\nCITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  \u00a0\nWATER (UNII: 059QF0KO0R)  \u00a0\nSODIUM HYDROXIDE (UNII: 55X04QC32I)  \u00a0\nHYDROCHLORIC ACID (UNII: QTT17582CB)  \u00a0\nBENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  \u00a0\n\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-128-351  in 1 CARTON03/15/2021\n\n\n12.5 mL in 1 BOTTLE; Type 0: Not a Combination Product\n\n\n2NDC:42571-128-211  in 1 CARTON03/15/2021\n\n\n25 mL in 1 BOTTLE; Type 0: Not a Combination Product\n\n\n3NDC:42571-128-281  in 1 CARTON03/15/2021\n\n\n37.5 mL in 1 BOTTLE; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-128-35 1  in 1 CARTON 03/15/2021  1  2.5 mL in 1 BOTTLE; Type 0: Not a Combination Product   2 NDC:42571-128-21 1  in 1 CARTON 03/15/2021  2  5 mL in 1 BOTTLE; Type 0: Not a Combination Product   3 NDC:42571-128-28 1  in 1 CARTON 03/15/2021  3  7.5 mL in 1 BOTTLE; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-128-35 1  in 1 CARTON 03/15/2021 \n1  2.5 mL in 1 BOTTLE; Type 0: Not a Combination Product  \n2 NDC:42571-128-21 1  in 1 CARTON 03/15/2021 \n2  5 mL in 1 BOTTLE; Type 0: Not a Combination Product  \n3 NDC:42571-128-28 1  in 1 CARTON 03/15/2021 \n3  7.5 mL in 1 BOTTLE; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20250503/15/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA202505 03/15/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA202505 03/15/2021 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  677600482 analysis(42571-128) , label(42571-128) , manufacture(42571-128) , pack(42571-128) \nBIMATOPROST\n\u00a0\t\t\n\t\t\t\t\t\n\nbimatoprost solution/ drops\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-128\n\n\nRoute of AdministrationOPHTHALMIC\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-128 Route of Administration OPHTHALMIC\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-128\nRoute of Administration OPHTHALMIC\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nBIMATOPROST (UNII: QXS94885MZ)  (BIMATOPROST - UNII:QXS94885MZ) BIMATOPROST0.3\u00a0mg \u00a0in\u00a01\u00a0mL\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BIMATOPROST (UNII: QXS94885MZ)  (BIMATOPROST - UNII:QXS94885MZ)  BIMATOPROST 0.3\u00a0mg \u00a0in\u00a01\u00a0mL\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nBIMATOPROST (UNII: QXS94885MZ)  (BIMATOPROST - UNII:QXS94885MZ)  BIMATOPROST 0.3\u00a0mg \u00a0in\u00a01\u00a0mL\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSODIUM CHLORIDE (UNII: 451W47IQ8X) \u00a0\n\n\nSODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE (UNII: 70WT22SF4B) \u00a0\n\n\nCITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) \u00a0\n\n\nWATER (UNII: 059QF0KO0R) \u00a0\n\n\nSODIUM HYDROXIDE (UNII: 55X04QC32I) \u00a0\n\n\nHYDROCHLORIC ACID (UNII: QTT17582CB) \u00a0\n\n\nBENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SODIUM CHLORIDE (UNII: 451W47IQ8X)  \u00a0 SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE (UNII: 70WT22SF4B)  \u00a0 CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  \u00a0 WATER (UNII: 059QF0KO0R)  \u00a0 SODIUM HYDROXIDE (UNII: 55X04QC32I)  \u00a0 HYDROCHLORIC ACID (UNII: QTT17582CB)  \u00a0 BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSODIUM CHLORIDE (UNII: 451W47IQ8X)  \u00a0\nSODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE (UNII: 70WT22SF4B)  \u00a0\nCITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  \u00a0\nWATER (UNII: 059QF0KO0R)  \u00a0\nSODIUM HYDROXIDE (UNII: 55X04QC32I)  \u00a0\nHYDROCHLORIC ACID (UNII: QTT17582CB)  \u00a0\nBENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  \u00a0\n\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-128-351  in 1 CARTON03/15/2021\n\n\n12.5 mL in 1 BOTTLE; Type 0: Not a Combination Product\n\n\n2NDC:42571-128-211  in 1 CARTON03/15/2021\n\n\n25 mL in 1 BOTTLE; Type 0: Not a Combination Product\n\n\n3NDC:42571-128-281  in 1 CARTON03/15/2021\n\n\n37.5 mL in 1 BOTTLE; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-128-35 1  in 1 CARTON 03/15/2021  1  2.5 mL in 1 BOTTLE; Type 0: Not a Combination Product   2 NDC:42571-128-21 1  in 1 CARTON 03/15/2021  2  5 mL in 1 BOTTLE; Type 0: Not a Combination Product   3 NDC:42571-128-28 1  in 1 CARTON 03/15/2021  3  7.5 mL in 1 BOTTLE; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-128-35 1  in 1 CARTON 03/15/2021 \n1  2.5 mL in 1 BOTTLE; Type 0: Not a Combination Product  \n2 NDC:42571-128-21 1  in 1 CARTON 03/15/2021 \n2  5 mL in 1 BOTTLE; Type 0: Not a Combination Product  \n3 NDC:42571-128-28 1  in 1 CARTON 03/15/2021 \n3  7.5 mL in 1 BOTTLE; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20250503/15/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA202505 03/15/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA202505 03/15/2021 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  677600482 analysis(42571-128) , label(42571-128) , manufacture(42571-128) , pack(42571-128) \nBIMATOPROST\n\u00a0\t\t\n\t\t\t\t\t\n\nbimatoprost solution/ drops\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-128\n\n\nRoute of AdministrationOPHTHALMIC\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-128 Route of Administration OPHTHALMIC\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-128\nRoute of Administration OPHTHALMIC\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nBIMATOPROST (UNII: QXS94885MZ)  (BIMATOPROST - UNII:QXS94885MZ) BIMATOPROST0.3\u00a0mg \u00a0in\u00a01\u00a0mL\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BIMATOPROST (UNII: QXS94885MZ)  (BIMATOPROST - UNII:QXS94885MZ)  BIMATOPROST 0.3\u00a0mg \u00a0in\u00a01\u00a0mL\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nBIMATOPROST (UNII: QXS94885MZ)  (BIMATOPROST - UNII:QXS94885MZ)  BIMATOPROST 0.3\u00a0mg \u00a0in\u00a01\u00a0mL\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nSODIUM CHLORIDE (UNII: 451W47IQ8X) \u00a0\n\n\nSODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE (UNII: 70WT22SF4B) \u00a0\n\n\nCITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) \u00a0\n\n\nWATER (UNII: 059QF0KO0R) \u00a0\n\n\nSODIUM HYDROXIDE (UNII: 55X04QC32I) \u00a0\n\n\nHYDROCHLORIC ACID (UNII: QTT17582CB) \u00a0\n\n\nBENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength SODIUM CHLORIDE (UNII: 451W47IQ8X)  \u00a0 SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE (UNII: 70WT22SF4B)  \u00a0 CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  \u00a0 WATER (UNII: 059QF0KO0R)  \u00a0 SODIUM HYDROXIDE (UNII: 55X04QC32I)  \u00a0 HYDROCHLORIC ACID (UNII: QTT17582CB)  \u00a0 BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nSODIUM CHLORIDE (UNII: 451W47IQ8X)  \u00a0\nSODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE (UNII: 70WT22SF4B)  \u00a0\nCITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  \u00a0\nWATER (UNII: 059QF0KO0R)  \u00a0\nSODIUM HYDROXIDE (UNII: 55X04QC32I)  \u00a0\nHYDROCHLORIC ACID (UNII: QTT17582CB)  \u00a0\nBENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  \u00a0\n\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-128-351  in 1 CARTON03/15/2021\n\n\n12.5 mL in 1 BOTTLE; Type 0: Not a Combination Product\n\n\n2NDC:42571-128-211  in 1 CARTON03/15/2021\n\n\n25 mL in 1 BOTTLE; Type 0: Not a Combination Product\n\n\n3NDC:42571-128-281  in 1 CARTON03/15/2021\n\n\n37.5 mL in 1 BOTTLE; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-128-35 1  in 1 CARTON 03/15/2021  1  2.5 mL in 1 BOTTLE; Type 0: Not a Combination Product   2 NDC:42571-128-21 1  in 1 CARTON 03/15/2021  2  5 mL in 1 BOTTLE; Type 0: Not a Combination Product   3 NDC:42571-128-28 1  in 1 CARTON 03/15/2021  3  7.5 mL in 1 BOTTLE; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-128-35 1  in 1 CARTON 03/15/2021 \n1  2.5 mL in 1 BOTTLE; Type 0: Not a Combination Product  \n2 NDC:42571-128-21 1  in 1 CARTON 03/15/2021 \n2  5 mL in 1 BOTTLE; Type 0: Not a Combination Product  \n3 NDC:42571-128-28 1  in 1 CARTON 03/15/2021 \n3  7.5 mL in 1 BOTTLE; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20250503/15/2021\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA202505 03/15/2021 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA202505 03/15/2021 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  677600482 analysis(42571-128) , label(42571-128) , manufacture(42571-128) , pack(42571-128)",
    "dosage": null,
    "contraindications": null,
    "side_effects": null,
    "warnings": null
  },
  {
    "product_name": "Celecoxib capsules",
    "INGREDIENTS AND APPEARANCE": "CELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-142\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-142 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-142\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB50\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 50\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 50\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size14mm\n\n\nFlavorImprint Code\n                           \n                           M;11\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 14mm Flavor  Imprint Code \n                           \n                           M;11\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 14mm\nFlavor  Imprint Code \n                           \n                           M;11\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-142-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-142-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-142-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-142-337  in 1 CARTON06/01/2018\n\n\n4NDC:42571-142-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-142-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-142-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-142-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-142-33 7  in 1 CARTON 06/01/2018  4 NDC:42571-142-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-142-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-142-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-142-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-142-33 7  in 1 CARTON 06/01/2018 \n4 NDC:42571-142-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-143\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-143 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-143\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB100\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 100\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 100\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size16mm\n\n\nFlavorImprint Code\n                           \n                           M;12\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 16mm Flavor  Imprint Code \n                           \n                           M;12\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 16mm\nFlavor  Imprint Code \n                           \n                           M;12\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-143-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-143-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-143-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-143-337  in 1 CARTON06/01/2018\n\n\n4NDC:42571-143-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n5NDC:42571-143-01100  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-143-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-143-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-143-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-143-33 7  in 1 CARTON 06/01/2018  4 NDC:42571-143-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product   5 NDC:42571-143-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-143-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-143-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-143-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-143-33 7  in 1 CARTON 06/01/2018 \n4 NDC:42571-143-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n5 NDC:42571-143-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-144\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-144 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-144\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB200\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 200\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 200\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size19mm\n\n\nFlavorImprint Code\n                           \n                           M;13\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 19mm Flavor  Imprint Code \n                           \n                           M;13\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 19mm\nFlavor  Imprint Code \n                           \n                           M;13\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-144-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-144-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-144-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-144-296  in 1 CARTON06/01/2018\n\n\n4NDC:42571-144-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n5NDC:42571-144-01100  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-144-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-144-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-144-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-144-29 6  in 1 CARTON 06/01/2018  4 NDC:42571-144-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product   5 NDC:42571-144-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-144-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-144-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-144-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-144-29 6  in 1 CARTON 06/01/2018 \n4 NDC:42571-144-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n5 NDC:42571-144-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-145\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-145 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-145\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB400\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 400\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 400\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size23mm\n\n\nFlavorImprint Code\n                           \n                           M;14\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 23mm Flavor  Imprint Code \n                           \n                           M;14\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 23mm\nFlavor  Imprint Code \n                           \n                           M;14\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-145-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-145-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-145-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-145-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-145-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-145-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-142, 42571-143, 42571-144, 42571-145) , label(42571-142, 42571-143, 42571-144, 42571-145) , manufacture(42571-142, 42571-143, 42571-144, 42571-145) , pack(42571-142, 42571-143, 42571-144, 42571-145) \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-142\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-142 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-142\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB50\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 50\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 50\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size14mm\n\n\nFlavorImprint Code\n                           \n                           M;11\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 14mm Flavor  Imprint Code \n                           \n                           M;11\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 14mm\nFlavor  Imprint Code \n                           \n                           M;11\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-142-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-142-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-142-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-142-337  in 1 CARTON06/01/2018\n\n\n4NDC:42571-142-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-142-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-142-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-142-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-142-33 7  in 1 CARTON 06/01/2018  4 NDC:42571-142-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-142-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-142-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-142-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-142-33 7  in 1 CARTON 06/01/2018 \n4 NDC:42571-142-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-143\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-143 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-143\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB100\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 100\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 100\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size16mm\n\n\nFlavorImprint Code\n                           \n                           M;12\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 16mm Flavor  Imprint Code \n                           \n                           M;12\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 16mm\nFlavor  Imprint Code \n                           \n                           M;12\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-143-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-143-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-143-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-143-337  in 1 CARTON06/01/2018\n\n\n4NDC:42571-143-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n5NDC:42571-143-01100  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-143-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-143-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-143-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-143-33 7  in 1 CARTON 06/01/2018  4 NDC:42571-143-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product   5 NDC:42571-143-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-143-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-143-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-143-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-143-33 7  in 1 CARTON 06/01/2018 \n4 NDC:42571-143-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n5 NDC:42571-143-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-144\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-144 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-144\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB200\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 200\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 200\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size19mm\n\n\nFlavorImprint Code\n                           \n                           M;13\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 19mm Flavor  Imprint Code \n                           \n                           M;13\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 19mm\nFlavor  Imprint Code \n                           \n                           M;13\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-144-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-144-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-144-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-144-296  in 1 CARTON06/01/2018\n\n\n4NDC:42571-144-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n5NDC:42571-144-01100  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-144-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-144-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-144-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-144-29 6  in 1 CARTON 06/01/2018  4 NDC:42571-144-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product   5 NDC:42571-144-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-144-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-144-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-144-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-144-29 6  in 1 CARTON 06/01/2018 \n4 NDC:42571-144-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n5 NDC:42571-144-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-145\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-145 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-145\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB400\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 400\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 400\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size23mm\n\n\nFlavorImprint Code\n                           \n                           M;14\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 23mm Flavor  Imprint Code \n                           \n                           M;14\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 23mm\nFlavor  Imprint Code \n                           \n                           M;14\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-145-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-145-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-145-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-145-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-145-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-145-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-142, 42571-143, 42571-144, 42571-145) , label(42571-142, 42571-143, 42571-144, 42571-145) , manufacture(42571-142, 42571-143, 42571-144, 42571-145) , pack(42571-142, 42571-143, 42571-144, 42571-145) \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-142\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-142 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-142\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB50\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 50\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 50\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size14mm\n\n\nFlavorImprint Code\n                           \n                           M;11\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 14mm Flavor  Imprint Code \n                           \n                           M;11\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 14mm\nFlavor  Imprint Code \n                           \n                           M;11\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-142-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-142-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-142-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-142-337  in 1 CARTON06/01/2018\n\n\n4NDC:42571-142-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-142-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-142-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-142-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-142-33 7  in 1 CARTON 06/01/2018  4 NDC:42571-142-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-142-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-142-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-142-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-142-33 7  in 1 CARTON 06/01/2018 \n4 NDC:42571-142-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-143\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-143 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-143\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB100\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 100\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 100\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size16mm\n\n\nFlavorImprint Code\n                           \n                           M;12\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 16mm Flavor  Imprint Code \n                           \n                           M;12\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 16mm\nFlavor  Imprint Code \n                           \n                           M;12\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-143-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-143-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-143-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-143-337  in 1 CARTON06/01/2018\n\n\n4NDC:42571-143-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n5NDC:42571-143-01100  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-143-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-143-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-143-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-143-33 7  in 1 CARTON 06/01/2018  4 NDC:42571-143-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product   5 NDC:42571-143-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-143-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-143-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-143-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-143-33 7  in 1 CARTON 06/01/2018 \n4 NDC:42571-143-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n5 NDC:42571-143-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-144\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-144 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-144\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB200\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 200\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 200\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size19mm\n\n\nFlavorImprint Code\n                           \n                           M;13\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 19mm Flavor  Imprint Code \n                           \n                           M;13\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 19mm\nFlavor  Imprint Code \n                           \n                           M;13\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-144-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-144-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-144-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-144-296  in 1 CARTON06/01/2018\n\n\n4NDC:42571-144-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n5NDC:42571-144-01100  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-144-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-144-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-144-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-144-29 6  in 1 CARTON 06/01/2018  4 NDC:42571-144-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product   5 NDC:42571-144-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-144-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-144-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-144-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-144-29 6  in 1 CARTON 06/01/2018 \n4 NDC:42571-144-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n5 NDC:42571-144-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-145\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-145 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-145\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB400\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 400\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 400\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size23mm\n\n\nFlavorImprint Code\n                           \n                           M;14\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 23mm Flavor  Imprint Code \n                           \n                           M;14\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 23mm\nFlavor  Imprint Code \n                           \n                           M;14\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-145-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-145-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-145-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-145-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-145-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-145-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-142, 42571-143, 42571-144, 42571-145) , label(42571-142, 42571-143, 42571-144, 42571-145) , manufacture(42571-142, 42571-143, 42571-144, 42571-145) , pack(42571-142, 42571-143, 42571-144, 42571-145) \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-142\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-142 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-142\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB50\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 50\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 50\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size14mm\n\n\nFlavorImprint Code\n                           \n                           M;11\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 14mm Flavor  Imprint Code \n                           \n                           M;11\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 14mm\nFlavor  Imprint Code \n                           \n                           M;11\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-142-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-142-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-142-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-142-337  in 1 CARTON06/01/2018\n\n\n4NDC:42571-142-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-142-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-142-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-142-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-142-33 7  in 1 CARTON 06/01/2018  4 NDC:42571-142-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-142-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-142-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-142-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-142-33 7  in 1 CARTON 06/01/2018 \n4 NDC:42571-142-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-143\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-143 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-143\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB100\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 100\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 100\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size16mm\n\n\nFlavorImprint Code\n                           \n                           M;12\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 16mm Flavor  Imprint Code \n                           \n                           M;12\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 16mm\nFlavor  Imprint Code \n                           \n                           M;12\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-143-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-143-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-143-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-143-337  in 1 CARTON06/01/2018\n\n\n4NDC:42571-143-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n5NDC:42571-143-01100  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-143-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-143-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-143-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-143-33 7  in 1 CARTON 06/01/2018  4 NDC:42571-143-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product   5 NDC:42571-143-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-143-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-143-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-143-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-143-33 7  in 1 CARTON 06/01/2018 \n4 NDC:42571-143-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n5 NDC:42571-143-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-144\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-144 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-144\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB200\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 200\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 200\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size19mm\n\n\nFlavorImprint Code\n                           \n                           M;13\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 19mm Flavor  Imprint Code \n                           \n                           M;13\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 19mm\nFlavor  Imprint Code \n                           \n                           M;13\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-144-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-144-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-144-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-144-296  in 1 CARTON06/01/2018\n\n\n4NDC:42571-144-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n5NDC:42571-144-01100  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-144-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-144-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-144-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-144-29 6  in 1 CARTON 06/01/2018  4 NDC:42571-144-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product   5 NDC:42571-144-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-144-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-144-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-144-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-144-29 6  in 1 CARTON 06/01/2018 \n4 NDC:42571-144-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n5 NDC:42571-144-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-145\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-145 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-145\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB400\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 400\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 400\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size23mm\n\n\nFlavorImprint Code\n                           \n                           M;14\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 23mm Flavor  Imprint Code \n                           \n                           M;14\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 23mm\nFlavor  Imprint Code \n                           \n                           M;14\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-145-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-145-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-145-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-145-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-145-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-145-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-142, 42571-143, 42571-144, 42571-145) , label(42571-142, 42571-143, 42571-144, 42571-145) , manufacture(42571-142, 42571-143, 42571-144, 42571-145) , pack(42571-142, 42571-143, 42571-144, 42571-145) \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-142\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-142 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-142\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB50\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 50\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 50\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size14mm\n\n\nFlavorImprint Code\n                           \n                           M;11\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 14mm Flavor  Imprint Code \n                           \n                           M;11\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 14mm\nFlavor  Imprint Code \n                           \n                           M;11\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-142-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-142-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-142-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-142-337  in 1 CARTON06/01/2018\n\n\n4NDC:42571-142-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-142-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-142-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-142-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-142-33 7  in 1 CARTON 06/01/2018  4 NDC:42571-142-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-142-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-142-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-142-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-142-33 7  in 1 CARTON 06/01/2018 \n4 NDC:42571-142-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-143\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-143 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-143\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB100\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 100\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 100\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size16mm\n\n\nFlavorImprint Code\n                           \n                           M;12\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 16mm Flavor  Imprint Code \n                           \n                           M;12\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 16mm\nFlavor  Imprint Code \n                           \n                           M;12\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-143-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-143-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-143-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-143-337  in 1 CARTON06/01/2018\n\n\n4NDC:42571-143-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n5NDC:42571-143-01100  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-143-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-143-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-143-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-143-33 7  in 1 CARTON 06/01/2018  4 NDC:42571-143-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product   5 NDC:42571-143-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-143-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-143-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-143-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-143-33 7  in 1 CARTON 06/01/2018 \n4 NDC:42571-143-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n5 NDC:42571-143-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-144\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-144 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-144\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB200\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 200\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 200\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size19mm\n\n\nFlavorImprint Code\n                           \n                           M;13\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 19mm Flavor  Imprint Code \n                           \n                           M;13\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 19mm\nFlavor  Imprint Code \n                           \n                           M;13\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-144-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-144-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-144-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-144-296  in 1 CARTON06/01/2018\n\n\n4NDC:42571-144-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n5NDC:42571-144-01100  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-144-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-144-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-144-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-144-29 6  in 1 CARTON 06/01/2018  4 NDC:42571-144-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product   5 NDC:42571-144-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-144-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-144-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-144-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-144-29 6  in 1 CARTON 06/01/2018 \n4 NDC:42571-144-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n5 NDC:42571-144-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-145\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-145 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-145\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB400\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 400\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 400\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size23mm\n\n\nFlavorImprint Code\n                           \n                           M;14\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 23mm Flavor  Imprint Code \n                           \n                           M;14\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 23mm\nFlavor  Imprint Code \n                           \n                           M;14\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-145-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-145-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-145-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-145-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-145-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-145-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-142, 42571-143, 42571-144, 42571-145) , label(42571-142, 42571-143, 42571-144, 42571-145) , manufacture(42571-142, 42571-143, 42571-144, 42571-145) , pack(42571-142, 42571-143, 42571-144, 42571-145) \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-142\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-142 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-142\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB50\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 50\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 50\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size14mm\n\n\nFlavorImprint Code\n                           \n                           M;11\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 14mm Flavor  Imprint Code \n                           \n                           M;11\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 14mm\nFlavor  Imprint Code \n                           \n                           M;11\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-142-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-142-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-142-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-142-337  in 1 CARTON06/01/2018\n\n\n4NDC:42571-142-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-142-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-142-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-142-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-142-33 7  in 1 CARTON 06/01/2018  4 NDC:42571-142-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-142-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-142-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-142-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-142-33 7  in 1 CARTON 06/01/2018 \n4 NDC:42571-142-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-143\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-143 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-143\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB100\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 100\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 100\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size16mm\n\n\nFlavorImprint Code\n                           \n                           M;12\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 16mm Flavor  Imprint Code \n                           \n                           M;12\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 16mm\nFlavor  Imprint Code \n                           \n                           M;12\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-143-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-143-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-143-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-143-337  in 1 CARTON06/01/2018\n\n\n4NDC:42571-143-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n5NDC:42571-143-01100  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-143-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-143-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-143-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-143-33 7  in 1 CARTON 06/01/2018  4 NDC:42571-143-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product   5 NDC:42571-143-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-143-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-143-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-143-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-143-33 7  in 1 CARTON 06/01/2018 \n4 NDC:42571-143-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n5 NDC:42571-143-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-144\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-144 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-144\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB200\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 200\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 200\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size19mm\n\n\nFlavorImprint Code\n                           \n                           M;13\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 19mm Flavor  Imprint Code \n                           \n                           M;13\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 19mm\nFlavor  Imprint Code \n                           \n                           M;13\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-144-3030  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-144-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n3NDC:42571-144-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n4NDC:42571-144-296  in 1 CARTON06/01/2018\n\n\n4NDC:42571-144-3210  in 1 BLISTER PACK; Type 0: Not a Combination Product\n\n\n5NDC:42571-144-01100  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-144-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-144-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  3 NDC:42571-144-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  4 NDC:42571-144-29 6  in 1 CARTON 06/01/2018  4 NDC:42571-144-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product   5 NDC:42571-144-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-144-30 30  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-144-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n3 NDC:42571-144-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n4 NDC:42571-144-29 6  in 1 CARTON 06/01/2018 \n4 NDC:42571-144-32 10  in 1 BLISTER PACK; Type 0: Not a Combination Product  \n5 NDC:42571-144-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nCELECOXIB\n\u00a0\t\t\n\t\t\t\t\t\n\ncelecoxib capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-145\n\n\nRoute of AdministrationORAL\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-145 Route of Administration ORAL\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-145\nRoute of Administration ORAL\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L) CELECOXIB400\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 400\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCELECOXIB (UNII: JCX84Q7J1L)  (CELECOXIB - UNII:JCX84Q7J1L)  CELECOXIB 400\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48) \u00a0\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nPOVIDONE (UNII: FZ989GH94E) \u00a0\n\n\nSODIUM LAURYL SULFATE (UNII: 368GB5141J) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nSHELLAC (UNII: 46N107B71O) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0 LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 POVIDONE (UNII: FZ989GH94E)  \u00a0 SODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 SHELLAC (UNII: 46N107B71O)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0 PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nCROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  \u00a0\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nPOVIDONE (UNII: FZ989GH94E)  \u00a0\nSODIUM LAURYL SULFATE (UNII: 368GB5141J)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nSHELLAC (UNII: 46N107B71O)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nPROPYLENE GLYCOL (UNII: 6DC9Q167V3)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorwhite (white) Scoreno score\n\n\nShapeCAPSULE (capsule) Size23mm\n\n\nFlavorImprint Code\n                           \n                           M;14\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color white (white)  Score no score Shape CAPSULE (capsule)  Size 23mm Flavor  Imprint Code \n                           \n                           M;14\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor white (white)  Score no score\nShape CAPSULE (capsule)  Size 23mm\nFlavor  Imprint Code \n                           \n                           M;14\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-145-6060  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n2NDC:42571-145-05500  in 1 BOTTLE; Type 0: Not a Combination Product06/01/2018\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-145-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018  2 NDC:42571-145-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-145-60 60  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n2 NDC:42571-145-05 500  in 1 BOTTLE; Type 0: Not a Combination Product 06/01/2018 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA20477606/01/2018\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA204776 06/01/2018 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA204776 06/01/2018 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-142, 42571-143, 42571-144, 42571-145) , label(42571-142, 42571-143, 42571-144, 42571-145) , manufacture(42571-142, 42571-143, 42571-144, 42571-145) , pack(42571-142, 42571-143, 42571-144, 42571-145)",
    "dosage": null,
    "contraindications": null,
    "side_effects": null,
    "warnings": null
  },
  {
    "product_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP",
    "INGREDIENTS AND APPEARANCE": "CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE\n\u00a0\t\t\n\t\t\t\t\t\n\nchlordiazepoxide hcl and clidinium bromide capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-381\n\n\nRoute of AdministrationORALDEA ScheduleCIV\u00a0\u00a0\u00a0\u00a0\n\t\t\t\t\t\t\t\t\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-381 Route of Administration ORAL DEA Schedule CIV\u00a0\u00a0\u00a0\u00a0\n\t\t\t\t\t\t\t\t\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-381\nRoute of Administration ORAL DEA Schedule CIV\u00a0\u00a0\u00a0\u00a0\n\t\t\t\t\t\t\t\t\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCHLORDIAZEPOXIDE HYDROCHLORIDE (UNII: MFM6K1XWDK)  (CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR) CHLORDIAZEPOXIDE HYDROCHLORIDE5\u00a0mg\n\n\nCLIDINIUM BROMIDE (UNII: 91ZQW5JF1Z)  (CLIDINIUM - UNII:BO76JF850N) CLIDINIUM BROMIDE2.5\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CHLORDIAZEPOXIDE HYDROCHLORIDE (UNII: MFM6K1XWDK)  (CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR)  CHLORDIAZEPOXIDE HYDROCHLORIDE 5\u00a0mg CLIDINIUM BROMIDE (UNII: 91ZQW5JF1Z)  (CLIDINIUM - UNII:BO76JF850N)  CLIDINIUM BROMIDE 2.5\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCHLORDIAZEPOXIDE HYDROCHLORIDE (UNII: MFM6K1XWDK)  (CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR)  CHLORDIAZEPOXIDE HYDROCHLORIDE 5\u00a0mg\nCLIDINIUM BROMIDE (UNII: 91ZQW5JF1Z)  (CLIDINIUM - UNII:BO76JF850N)  CLIDINIUM BROMIDE 2.5\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFD&C BLUE NO. 1 (UNII: H3R47K3TBD) \u00a0\n\n\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nSHELLAC (UNII: MB5IUD6JUA) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  \u00a0 D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 SHELLAC (UNII: MB5IUD6JUA)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFD&C BLUE NO. 1 (UNII: H3R47K3TBD)  \u00a0\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nSHELLAC (UNII: MB5IUD6JUA)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorgreenScoreno score\n\n\nShapeCAPSULESize15mm\n\n\nFlavorImprint Code\n                           \n                           ML;5;2;5\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color green Score no score Shape CAPSULE Size 15mm Flavor  Imprint Code \n                           \n                           ML;5;2;5\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor green Score no score\nShape CAPSULE Size 15mm\nFlavor  Imprint Code \n                           \n                           ML;5;2;5\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-381-01100  in 1 BOTTLE; Type 0: Not a Combination Product10/01/2022\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-381-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 10/01/2022 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-381-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 10/01/2022 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA21583510/01/2022\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA215835 10/01/2022 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA215835 10/01/2022 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-381) , label(42571-381) , manufacture(42571-381) , pack(42571-381) \nCHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE\n\u00a0\t\t\n\t\t\t\t\t\n\nchlordiazepoxide hcl and clidinium bromide capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-381\n\n\nRoute of AdministrationORALDEA ScheduleCIV\u00a0\u00a0\u00a0\u00a0\n\t\t\t\t\t\t\t\t\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-381 Route of Administration ORAL DEA Schedule CIV\u00a0\u00a0\u00a0\u00a0\n\t\t\t\t\t\t\t\t\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-381\nRoute of Administration ORAL DEA Schedule CIV\u00a0\u00a0\u00a0\u00a0\n\t\t\t\t\t\t\t\t\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCHLORDIAZEPOXIDE HYDROCHLORIDE (UNII: MFM6K1XWDK)  (CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR) CHLORDIAZEPOXIDE HYDROCHLORIDE5\u00a0mg\n\n\nCLIDINIUM BROMIDE (UNII: 91ZQW5JF1Z)  (CLIDINIUM - UNII:BO76JF850N) CLIDINIUM BROMIDE2.5\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CHLORDIAZEPOXIDE HYDROCHLORIDE (UNII: MFM6K1XWDK)  (CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR)  CHLORDIAZEPOXIDE HYDROCHLORIDE 5\u00a0mg CLIDINIUM BROMIDE (UNII: 91ZQW5JF1Z)  (CLIDINIUM - UNII:BO76JF850N)  CLIDINIUM BROMIDE 2.5\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCHLORDIAZEPOXIDE HYDROCHLORIDE (UNII: MFM6K1XWDK)  (CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR)  CHLORDIAZEPOXIDE HYDROCHLORIDE 5\u00a0mg\nCLIDINIUM BROMIDE (UNII: 91ZQW5JF1Z)  (CLIDINIUM - UNII:BO76JF850N)  CLIDINIUM BROMIDE 2.5\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFD&C BLUE NO. 1 (UNII: H3R47K3TBD) \u00a0\n\n\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nSHELLAC (UNII: MB5IUD6JUA) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  \u00a0 D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 SHELLAC (UNII: MB5IUD6JUA)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFD&C BLUE NO. 1 (UNII: H3R47K3TBD)  \u00a0\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nSHELLAC (UNII: MB5IUD6JUA)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorgreenScoreno score\n\n\nShapeCAPSULESize15mm\n\n\nFlavorImprint Code\n                           \n                           ML;5;2;5\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color green Score no score Shape CAPSULE Size 15mm Flavor  Imprint Code \n                           \n                           ML;5;2;5\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor green Score no score\nShape CAPSULE Size 15mm\nFlavor  Imprint Code \n                           \n                           ML;5;2;5\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-381-01100  in 1 BOTTLE; Type 0: Not a Combination Product10/01/2022\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-381-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 10/01/2022 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-381-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 10/01/2022 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA21583510/01/2022\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA215835 10/01/2022 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA215835 10/01/2022 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-381) , label(42571-381) , manufacture(42571-381) , pack(42571-381) \nCHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE\n\u00a0\t\t\n\t\t\t\t\t\n\nchlordiazepoxide hcl and clidinium bromide capsule\n\n\n\nProduct Information\n\n\nProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42571-381\n\n\nRoute of AdministrationORALDEA ScheduleCIV\u00a0\u00a0\u00a0\u00a0\n\t\t\t\t\t\t\t\t\n\n\n Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-381 Route of Administration ORAL DEA Schedule CIV\u00a0\u00a0\u00a0\u00a0\n\t\t\t\t\t\t\t\t\nProduct Information\nProduct Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42571-381\nRoute of Administration ORAL DEA Schedule CIV\u00a0\u00a0\u00a0\u00a0\n\t\t\t\t\t\t\t\t\n\n\n\nActive Ingredient/Active Moiety\n\n\nIngredient NameBasis of StrengthStrength\n\n\nCHLORDIAZEPOXIDE HYDROCHLORIDE (UNII: MFM6K1XWDK)  (CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR) CHLORDIAZEPOXIDE HYDROCHLORIDE5\u00a0mg\n\n\nCLIDINIUM BROMIDE (UNII: 91ZQW5JF1Z)  (CLIDINIUM - UNII:BO76JF850N) CLIDINIUM BROMIDE2.5\u00a0mg\n\n\n Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CHLORDIAZEPOXIDE HYDROCHLORIDE (UNII: MFM6K1XWDK)  (CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR)  CHLORDIAZEPOXIDE HYDROCHLORIDE 5\u00a0mg CLIDINIUM BROMIDE (UNII: 91ZQW5JF1Z)  (CLIDINIUM - UNII:BO76JF850N)  CLIDINIUM BROMIDE 2.5\u00a0mg\nActive Ingredient/Active Moiety\nIngredient Name Basis of Strength Strength\nCHLORDIAZEPOXIDE HYDROCHLORIDE (UNII: MFM6K1XWDK)  (CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR)  CHLORDIAZEPOXIDE HYDROCHLORIDE 5\u00a0mg\nCLIDINIUM BROMIDE (UNII: 91ZQW5JF1Z)  (CLIDINIUM - UNII:BO76JF850N)  CLIDINIUM BROMIDE 2.5\u00a0mg\n\n\n\nInactive Ingredients\n\n\nIngredient NameStrength\n\n\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) \u00a0\n\n\nSTARCH, CORN (UNII: O8232NY3SJ) \u00a0\n\n\nTALC (UNII: 7SEV7J4R1U) \u00a0\n\n\nMAGNESIUM STEARATE (UNII: 70097M6I30) \u00a0\n\n\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP) \u00a0\n\n\nFD&C BLUE NO. 1 (UNII: H3R47K3TBD) \u00a0\n\n\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G) \u00a0\n\n\nGELATIN (UNII: 2G86QN327L) \u00a0\n\n\nSHELLAC (UNII: MB5IUD6JUA) \u00a0\n\n\nFERROSOFERRIC OXIDE (UNII: XM0M87F357) \u00a0\n\n\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T) \u00a0\n\n\n Inactive Ingredients Ingredient Name Strength LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0 STARCH, CORN (UNII: O8232NY3SJ)  \u00a0 TALC (UNII: 7SEV7J4R1U)  \u00a0 MAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0 TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0 FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  \u00a0 D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0 GELATIN (UNII: 2G86QN327L)  \u00a0 SHELLAC (UNII: MB5IUD6JUA)  \u00a0 FERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0 POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\nInactive Ingredients\nIngredient Name Strength\nLACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  \u00a0\nSTARCH, CORN (UNII: O8232NY3SJ)  \u00a0\nTALC (UNII: 7SEV7J4R1U)  \u00a0\nMAGNESIUM STEARATE (UNII: 70097M6I30)  \u00a0\nTITANIUM DIOXIDE (UNII: 15FIX9V2JP)  \u00a0\nFD&C BLUE NO. 1 (UNII: H3R47K3TBD)  \u00a0\nD&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  \u00a0\nGELATIN (UNII: 2G86QN327L)  \u00a0\nSHELLAC (UNII: MB5IUD6JUA)  \u00a0\nFERROSOFERRIC OXIDE (UNII: XM0M87F357)  \u00a0\nPOTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  \u00a0\n\n\n\nProduct Characteristics\n\n\nColorgreenScoreno score\n\n\nShapeCAPSULESize15mm\n\n\nFlavorImprint Code\n                           \n                           ML;5;2;5\n                        \n\n\nContains\u00a0\u00a0\u00a0\u00a0\n\n\n Product Characteristics Color green Score no score Shape CAPSULE Size 15mm Flavor  Imprint Code \n                           \n                           ML;5;2;5\n                         Contains \u00a0\u00a0\u00a0\u00a0\nProduct Characteristics\nColor green Score no score\nShape CAPSULE Size 15mm\nFlavor  Imprint Code \n                           \n                           ML;5;2;5\n                        \nContains \u00a0\u00a0\u00a0\u00a0\n\n\n\nPackaging\n\n\n#Item CodePackage DescriptionMarketing Start DateMarketing End Date\n\n\n1NDC:42571-381-01100  in 1 BOTTLE; Type 0: Not a Combination Product10/01/2022\n\n\n Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42571-381-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 10/01/2022 \nPackaging\n# Item Code Package Description Marketing Start Date Marketing End Date\n1 NDC:42571-381-01 100  in 1 BOTTLE; Type 0: Not a Combination Product 10/01/2022 \n\n\n\n\nMarketing Information\n\n\nMarketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date\n\n\nANDAANDA21583510/01/2022\n\n\n Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA215835 10/01/2022 \nMarketing Information\nMarketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date\nANDA ANDA215835 10/01/2022 \nLabeler -\u00a0Micro Labs Limited\n\t\t\t\t\t\t\t(862174955)\n\t\t\t\t\t\t\nEstablishment\nName Address ID/FEI Business Operations\nMicro Labs Limited  915793658 analysis(42571-381) , label(42571-381) , manufacture(42571-381) , pack(42571-381)",
    "dosage": null,
    "contraindications": null,
    "side_effects": null,
    "warnings": null
  }
]